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INTRODUCTION 
 Cervical lymphadenopathy  results from a vast group of disease 
whose broad categories can be easily recalled by the acronym 
‘‘MIAMI’’, representing Malignancies, Infections, Autoimmune 
disorders, Miscellaneous and unusual conditions, and Iatrogenic 
causes.17  Regional metastasis is an important factor in the treatment  
and prognosis of patients with oral cancer because the presence of 
metastatic node reduces the 5-year survival rate by 50% and the 
presence of another metastatic node on the contra-lateral side further 
reduces  the survival rate by 25%.3,4 ,38 ,70  
 An understanding of the mechanism by which tumour cells 
establish metastasis is crucial for tumour biology.29 Okura et al55 
suggested the possibility of suppression of cellular immune response 
in particular T-cell function in development of lymph node 
metastasis. Martinez–Gimeno et al46 have mentioned micro-vascular 
invasion, grade of differentiation and tumour thickness as important 
risk factors for metastasis. Nakayama et al52 stated that lymphatic 
vessel diameter and the mode of invasion may be the factors in the 
prediction of cervical lymph node metastases.  
 The management of oral cancer is based on the status of 
cervical lymph nodes so there is a need for an appropriate 
investigative procedure which can differentiate between metastatic 
and reactive lymph nodes in patient with oral cancer to aid in the 
grading and staging of the oral cancer which determines the 
treatment plan, prognosis and morbidity. 
 The characteristic event in tumour formation is angiogenesis 
and therefore the morphologic and hemodynamic changes that occur 
in tumour vessels can be used as a clue to differentiate between 
metastatic and reactive nodes. Blood vessel morphology in metastatic 
nodes is usually deranged as the internal nodal architecture is 
destroyed by neoplastic infiltration and neo-vascularisation induced 
by angiogenesis factor, whereas inflammation causes dilatation of 
intranodal vessels due to local humoral agents.  
 All these intranodal vascular alterations provide the potential 
for diagnosis, if vascular changes can be reliably detected. Colour 
Doppler Ultrasound is one of the advancement in sonography which 
can helps in differentiating metastatic from reactive nodes based on 
these vascular changes.53,5  
 Colour Doppler ultrasound (CDUS) is a non-invasive procedure 
that can define the morphologic and vascular characteristics of the 
lymph node. The presence of intra-nodal vascularity, its distribution 
and estimation of the intravascular resistance and spectral Doppler 
analysis are evaluated with colour Doppler.46  
 CDUS can be used to improve pre-operative staging of oral 
cancer. In selected cases this may direct the surgeons to convert the 
treatment plan to choose a more conservative neck dissection or to a 
more radical neck dissection.29 Studies have shown that there is a 
general tendency of the clinician to over-diagnose the cervical lymph 
nodes as metastatic in patients with oral cancer. CDUS can also 
avoid this over-diagnosis and can prevent the unnecessary removal of 
nodes in each and every patient with oral cancer.28 ,29   
 Therefore this study was conducted to evaluate the possibility 
of using CDUS as an alternative investigative procedure in 
differentiating metastatic nodes from reactive nodes in patients with 
oral cancer. This study also showed the importance of CDUS in 
discovery of clinically non-palpable cervical lymph nodes and value 
of CDUS in minimizing the need for Fine needle aspiration cytology 
(FNAC). 
 
 
 
 
NORMAL ANATOMY OF LYMPH NODE 
  
 Cervical lymph nodes are located along the lymphatic channels 
of the neck. Each cervical lymph node has cortical and medullary 
regions, and is covered by a fibrous capsule.21The cortex consists of 
lymphocytes which are densely packed together to form spherical 
lymphoid follicles, whereas the medulla is composed of medullary 
trabeculae, medullary cords and medullary sinuses.77  
 The para-cortex is an intermediate area between the cortex and 
the medulla, where the lymphocytes return to the lymphatic system 
from the blood circulation. In the medulla of the lymph node, the 
medullary trabeculae, composed of dense connective tissue similar to 
the capsule, act as a framework extending from the capsule and 
guides blood vessels and nerves to different regions of the lymph 
node. The medullary cords and medullary sinuses are composed of 
reticulum cells. The medullary cords contain mainly plasma cells and 
small lymphocytes, whilst the medullary sinuses are filled with 
lymph and are part of the sinus system of the lymph node.37 
 Cervical lymph nodes contain blood vessels. The main artery 
enters the lymph node at the hilus, which then branches into 
arterioles. Some of the arterioles supply the capillary bed in the 
medulla and some of them run along the medullary trabeculae to the 
cortex where the arterioles further branch into capillaries and supply 
the lymphoid follicles. The rest of the arterioles run along the 
trabeculae and reach the capsule where they anastomose with other 
branches.57 
 The venous system has a similar route as the arterial system. 
The venules converge to form small veins in the cortex. The small 
veins run along the trabeculae of the lymph node and reach the 
medulla where they further converge to form the main vein. The main 
vein leaves the lymph node at the hilus.21 ,57 ,37  
 
Classification of lymph nodes 
 There are about 800 lymph nodes in the body and about 300 
lymph nodes are located in the neck.66 The American Joint 
Committee on Cancer (AJCC, 1997) classification was developed to 
provide a simple and efficient way to classify the cervical lymph 
nodes and this classification is widely used by surgeons and 
oncologists.  
 The AJCC classification divides palpable cervical lymph nodes 
into seven levels which are based on the extent and level of cervical 
nodal involvement by metastatic tumour.15 
Level I contains the sub-mental and sub-mandibular triangles 
bounded by the posterior belly of the digastric muscle, the hyoid 
bone inferiorly, and the body of the mandible superiorly. 
Level II -contains the upper jugular lymph nodes and extends from 
the level of the skull base superiorly to the hyoid bone inferiorly. 
Level-III -contains the middle jugular lymph nodes from the hyoid 
bone superiorly to the cricothyroid membrane inferiorly. 
Level-IV- contains the lower jugular lymph nodes from the 
cricothyroid membrane superiorly to the clavicle inferiorly. 
Level-V -contains the lymph nodes in the posterior triangle bounded 
by the anterior border of the sternocleidomastoid muscle anteriorly 
and the clavicle inferiorly. For descriptive purposes, level V may be 
further subdivided into upper, middle, and lower levels 
corresponding to the superior and inferior planes that define levels 
II, III, and IV. 
Level-VI -contains the lymph nodes of the anterior compartment 
from the hyoid bone superiorly to the suprasternal notch inferiorly. 
They lie between the medial borders of the carotid sheaths. 
Level-VII  contains the lymph nodes inferior to the suprasternal notch 
in the upper mediastinum. 
 Retropharyngeal, parotid, facial, occipital, and other nodes are 
referred to by these names.          
 
 Since the AJCC classification is used in different imaging 
modalities such as computed tomography and magnetic resonance 
imaging, some lymph nodes in this classification may be difficult to 
be assessed by ultrasound, such as the paratracheal, prelaryngeal and 
upper mediastinal nodes.    
 In order to simplify the ultrasound examination of the neck and 
to ensure that all areas of the neck are covered in a systematic way, 
Hajek et al  36  developed another classification for ultrasound 
examination of the neck which is based on the location of the lymph 
nodes. 
 Region-1  includes lymph nodes located in sub-mental region.  
Region-2 lymph nodes located in submandibular region. 
Region-3 lymph nodes located in parotid region. 
Region-4 lymph nodes located in upper cervical region. 
Region-5 includes middle cervical nodes. 
Region-6 includes lower cervical nodes. 
Region-7 nodes located in supraclavicular fossa. 
Region-8 includes nodes in posterior triangle. 
 However, this classification is used to facilitate the ultrasound 
examination of the neck and should not be used for staging of 
carcinomas which is based on the AJCC classification. 
  
PRINCIPLE OF COLOUR DOPPLER SONOGRAPHY 
 
 Doppler effect is a change in the observed frequency of wave 
because of motion of the source or observer.48 Ultrasound images of 
flow are essentially obtained from measurements of movement. In 
ultrasound scanners, a series of pulses is transmitted to detect 
movement of blood. Echoes from stationary tissue are the same from 
pulse to pulse. Echoes from moving scatterers exhibit slight 
differences in the time for the signal to be returned to the receiver. 
These differences can be measured as a direct time difference or, 
more usually, in terms of a phase shift from which the ‘Doppler 
frequency’ is obtained. They are then processed to produce either a 
colour flow display or a Doppler sonogram. 
 
Figure 1:  Doppler  u l trasound.  Doppler  u l trasound measures  the movement  of  the 
scat terers  through the beam as a  phase change in  the received s ignal .  The resul t ing 
Doppler  f requency can be used to  measure veloci ty if  the beam/f low angle is  known.  
 The size of the Doppler signal is dependent on Blood velocity 
(as velocity increases, so does the Doppler frequency); ultrasound 
frequency (higher ultrasound frequencies give increased Doppler 
frequency) the choice of frequency is a compromise between better 
sensitivity to flow or better penetration; the angle of insonation  (the 
Doppler frequency increases as the Doppler Ultrasound beam 
becomes more aligned to the flow direction). 
 All types of Doppler ultrasound equipment employ filters to cut 
out the high amplitude, low-frequency Doppler signals resulting from 
tissue movement, for instance due to vessel wall motion.  
CONTINUOUS WAVE AND PULSED WAVE: 
 As the name suggests, continuous wave systems use continuous 
transmission and reception of ultrasound. Continuous wave Doppler 
ultrasound is unable to determine the specific location of velocities 
within the beam and cannot be used to produce colour flow images.  
 Continuous wave Doppler is used in adult cardiac scanners to 
investigate the high velocities in the aorta.Doppler ultrasound in 
general and obstetric ultrasound scanners uses pulsed wave 
ultrasound. This allows measurement of the depth (or range) of the 
flow site. Additionally, the size of the sample volume (or range gate) 
can be changed. Pulsed wave ultrasound is used to provide data for 
Doppler sonograms and color flow images. 
Aliasing: When pulses are transmitted at a given sampling frequency 
(known as the pulse repetition frequency), the maximum Doppler 
frequency (fd) that can be measured unambiguously is half the pulse 
repetition frequency. If the blood velocity and beam/flow angle being 
measured combine to give an fd  value greater than half of the pulse 
repetition frequency, ambiguity in the Doppler signal occurs. This 
ambiguity is known as aliasing . 
 The pulse repetition frequency is itself constrained by the 
range of the sample volume. The time interval between sampling 
pulses must be sufficient for a pulse to make the return journey from 
the transducer to the reflector and back. If a second pulse is sent 
before the first is received, the receiver cannot discriminate between 
the reflected signal from both pulses and ambiguity in the range of 
the sample volume ensues.  
 As the depth of investigation increases, the journey time of the 
pulse to and from the reflector is increased, reducing the pulse 
repetition frequency for unambiguous ranging. The result is that the 
maximum fd  measurable decreases with depth. Low pulse repetition 
frequencies are employed to examine low velocities (e.g. venous 
flow). The longer interval between pulses allows the scanner a better 
chance of identifying slow flow.  
 Aliasing will occur if low pulse repetition frequencies or 
velocity scales are used and high velocities are encountered. 
Conversely, if a high pulse repetition frequency is used to examine 
high velocities; low velocities may not be identified. Since colour 
flow imaging provides a limited amount of information over a large 
region, and spectral Doppler provides more detailed information 
about a small region, the two modes are complementary and, in 
practice, are used as such.  
 Colour flow imaging can be used to identify vessels requiring 
examination, to identify the presence and direction of flow, to 
highlight gross circulation anomalies, throughout the entire colour 
flow image, and to provide beam/vessel angle correction for velocity 
measurements.  
 Pulsed wave Doppler is used to provide analysis of the flow at 
specific sites in the vessel under investigation. When using colour 
flow imaging with pulsed wave Doppler, the colour flow/B-mode 
image is frozen while the pulsed wave Doppler is activated. 
Recently, some manufacturers have produced concurrent colour flow 
imaging and pulsed wave Doppler, sometimes referred to as triplex 
scanning. 
COLOUR FLOW IMAGING: 
 Colour flow Doppler ultrasound produces a colour-coded map 
of Doppler shifts superimposed onto a B-mode ultrasound image 
(Colour Flow Maps). Although colour flow imaging uses pulsed 
wave ultrasound, its processing differs from that used to provide the 
Doppler sonogram.  
 Colour flow imaging may have to produce several thousand 
colour points of flow information for each frame superimposed on the 
B-mode image. Colour flow imaging uses fewer, shorter pulses along 
each colour scan line of the image to give a mean frequency shift and 
a variance at each small area of measurement. This frequency shift is 
displayed as a colour pixel. The scanner then repeats this for several 
lines to build up the colour image, which is superimposed onto the B-
mode image. The transducer elements are switched rapidly between 
B-mode and colour flow imaging to give an impression of a combined 
simultaneous image.  
 The pulses used for colour flow imaging are typically three to 
four times longer than those for the B-mode image, with a 
corresponding loss of axial resolution. Assignment of colour to 
frequency shifts is usually based on direction (for example, red for 
Doppler shifts towards the ultrasound beam and blue for shifts away 
from it) and magnitude (different colour hues or lighter saturation for 
higher frequency shifts).  
 The colour Doppler image is dependent on general Doppler 
factors, particularly the need for a good beam/flow angle. Curvilinear 
and phased array transducers have a radiating pattern of ultrasound 
beams that can produce complex colour flow images, depending on 
the orientation of the arteries and veins. 
 Factors affecting colour flow image includes Power 
(transmitted power into tissue),Gain(overall sensitivity to flow 
signals)Frequency , Pulse repetition frequency also called 
scale(high pulse repetition frequency reduces aliasing),Area of 
investigation( larger area reduces frame rate), Focus (colour flow 
image optimized at focal zone),Triplex  colour (pulse repetition 
frequency and frame rate reduced by need for B-mode/spectral 
pulses), Persistence ( high persistence produces smoother image but 
reduces temporal resolution), Pre-processing ( trades resolution 
against frame rate), Filter (high filter cuts out more noise but also 
more of flow signal), Post-processing (assigns colour map/variance). 
SPECTRAL OR PULSED WAVE DOPPLER: 
 Pulsed wave Doppler ultrasound is used to provide a sonogram 
of the artery or vein under investigation. The sonogram provides a 
measure of the changing velocity throughout the cardiac cycle and 
the distribution of velocities in the sample volume (or gate) .If an 
accurate angle correction is made, then absolute velocities can be 
measured.  
 The best resolution of the sonogram occurs when the B-mode 
image and colour image are frozen, allowing all the time to be 
employed for spectral Doppler. If concurrent imaging is used (real-
time duplex or triplex imaging), the temporal resolution of the 
sonogram is compromised.  
Factors’ affecting the spectral image includes: 
 Gait  (sharpness of resolution), Filter (high filter cuts out 
more noise but more of flow signal), Post-processing (assigns 
brightness to output), Power  (transmitted power into tissue), Gain  
(overall sensitivity to flow signals), Pulse repetition  frequency  also 
called scale (low pulse repetition frequency to look at low velocities, 
high pulse repetition frequency reduces aliasing), Gate size  (Beam 
steering can allow improved beam/flow angle for better accuracy of 
velocity calculation). 
Calculation of absolute flow:   
 Total flow measurement using color or duplex Doppler 
ultrasound is fraught with difficulties, even under ideal conditions.62 
Errors that may arise include: (1) Those due to inaccurate 
measurement of vessel cross-sectional area, for example the cross-
sectional area of arteries which pulsate during the cardiac cycle, (2) 
Those originating in the derivation of velocity.  
 These errors become particularly large when flow calculations 
are made in small vessels; errors in measurement of diameter are 
magnified when the diameter is used to derive cross-sectional area. 
As with velocity measurements, it is prudent to be aware of possible 
errors and to conduct repeatability tests. 
Flow waveform analysis:  
 Non-dimensional analysis of the flow waveform shape and 
spectrum has proved to be a useful technique in the investigation of 
many vascular beds. It has the advantage that derived indices are 
independent of the beam/flow angle. Many different indices have 
been used to describe the shape of flow waveforms.32 
 All are designed to describe the waveform in a quantitative 
way, usually as a guide to some kind of classification.  
 Commonly used indices available on most commercial scanners 
are: 
1. Resistance index (RI) (also called resistive index or 
Pourcelot’s index) 
2. Systolic/diastolic (S/D) ratio ,  sometimes called the A/B ratio 
3. Pulsatility  index  (PI) 
 These indices are all based on the maximum Doppler shift 
waveform. The PI takes slightly longer to calculate than the RI or 
S/D ratio because of the need to measure the mean height of the 
waveform. It does, however, give a broader range of values, for 
instance in describing a range of waveform shapes when there is no 
end-diastolic flow.  
 In addition to these indices, the flow waveform may be 
described or categorized by the presence or absence of a particular 
feature, for example the absence of end-diastolic flow and the 
presence of a post-systolic notch. Generally, a low Pulsatility 
waveform is indicative of low distal resistance and high Pulsatility 
waveforms occur in high-resistance vascular beds, although the 
presence of proximal stenosis, vascular steal or arterio-venous 
fistulas can modify waveform shape. 
 
            Figure 2: Arterial velocity sonogram (waveform). 
 
Figure 3 - Flow velocity indices 
 Care should be taken when trying to interpret indices as 
absolute measurements of either upstream or downstream factors. For 
example, alterations in heart rate can alter the flow waveform shape 
and cause significant changes in the value of indices. 
Potential use of CDUS in differentiating metastatic from reactive 
lymph nodes  
 The vascular pattern of the enlarged lymph nodes is classified 
into the following four groups, according to the location of the 
vascularity29:  
1. Central: flow signals branching radially from the centre, and 
signals are not along the periphery of the nodes.(Figure-1a) 
2. Peripheral: flow signals along the periphery of the lymph nodes, 
with branches perforating the periphery of the node and not 
arising from the hilar vessels. (Figure-1b) 
3. Mixed: The presence of central and peripheral flow signals. 
(Figure-1c) 
4. No flow: absence of vascular signals within the lymph nodes. The 
presence of blood flow signals in the centre of node suggests that 
the node is reactive. The presence of peripheral, mixed or no flow 
suggests a metastatic nature.(Figure-1d) 
 
  
Figure 1a.Central flow          Figure 1b.Peripheral flow 
    
 Figure 1c.Mixed flow                 Figure 1d.No flow 
 On-board software is used for the evaluation of the vascular 
resistance, resistive index (RI) and Pulsatility index (PI), peak 
systolic velocity and end diastolic velocity of lymph nodes. 
Resistivity Index=  
                                          
Pulsatility Index=                                             
 
 The presence of high intranodal vascular resistance has been 
used as a key feature to differentiate reactive from metastatic nodes. 
Peak Systolic Velocity-End Diastolic Velocity 
Peak Systolic Velocity 
Peak Systolic Velocity-End Diastolic Velocity 
Time-Averaged Maximum Velocity 
Metastatic nodes will have high PI and RI values as compared to low 
PI and RI values for Reactive nodes. 
FINE NEEDLE ASPIRATION CYTOLOGY (FNAC)   
 Aspiration of lymph nodes for diagnostic purposes was first 
done by Griey and Grayin 1904, in patients with sleeping sickness.26  
The experiment of fine needle aspiration (FNA) developed gradually, 
until 1921, when Guthrie35 tried to correlate FNA results with 
various disease processes. FNAC is in practice since the 1930s.  
 The use of fine needle aspiration cytology (FNAC) in the 
investigation of lymphadenopathy has become an acceptable and 
widely practised minimally invasive technique, which is safe, simple, 
rapid and relatively pain-free.            
 FNAC is highly cost effective and accurate as a first line 
investigative technique with differential diagnoses including reactive 
hyperplasia/inflammatory conditions, granulomatous disorders and 
malignancy, stratifying cases requiring further investigations, 
surgical intervention or clinical follow-up.44 
 The main benefit of FNAC is to avoid the need for surgical 
biopsy, which requires local or general anaesthesia, increased 
hospital stay and costs.60  Other advantages include It is economical, 
has better patient compliance, highly suitable for debilitated patient, 
readily repeatable and is useful for multiple lesions.56 ,59  The results 
are extremely satisfactory in good hands. The exact cytological 
diagnosis is available before definitive surgery is planned. It is cost 
contained procedure. It can relieve the anxiety and uncertainty in 
both patient and physician by making an accurate diagnosis 
preoperatively. 
 Diagnostic accuracy for metastatic lymph nodes approaches 
97.9%, with sensitivity of 97.9% & specificity of 100%.41 similar 
findings were observed by Kim et al who found them to be 97.9%, 
97.9%, 99.1% respectively.42 
 Various studies conducted by Lee et al45 and Nada51 al Alwan 
et al also had somewhat similar result.  
 Ultrasound guided Fine Needle Aspiration Cytology can further 
be useful in small or clinically non-palpable nodes where chances of 
aspirating sufficient material for microscopic examination are less. 
In a resource challenged environment like ours, FNAC still remains 
the most acceptable, cheap and easily accessible modality for the 
diagnosis of metastatic lymphadenopathy.  
Criteria used for diagnosing Reactive node by FNAC:56 
1. A mixed population of lymphoid cells. 
2. Numerical predominance of small lymphocytes. 
3. Centroblasts, centrocytes, immunoblasts and plasma cells in 
variable but ‘logical’ proportions. 
4. Dendritic reticulum cells associated with centroblasts and 
centrocytes (derived from germinal centres). 
5. Scattered histiocytes with intracytoplasmic nuclear debris 
(tangible body macrophages). 
6. Pale histiocytes, interdigitating cells, endothelial cells, 
eosinophils, neutrophils (variable). 
Criteria used for diagnosing Metastatic node by FNAC56: 
1. Abnormal nonlymphoid cells amongst normal/reactive 
lymphoid cells. 
2. Cytological criteria of malignancy. 
 
 
                        
 
 
 
 
 
 
AIMS AND OBJECTIVES 
 
1. To assess the diagnostic accuracy of CDUS in differentiating 
metastatic from reactive lymph nodes in oral cancer patients.  
2. To evaluate the status of clinically not-palpable lymph nodes. 
3. To correlate these findings with and Fine needle aspiration 
cytology (FNAC) findings. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
R. A. Mountford et al (1979)49  examined  pathologically enlarged 
lymph nodes with a commercially available 10 MHz continuous-wave 
Doppler flow meter. Many enlarged lymph nodes gave rise to 
significant Doppler-shift signals indicating increased blood flow. The 
signals have been spectrum analysed and the large diastolic flow 
components suggest that there is considerable arterio-venous 
shunting within lymph glands involved in leukaemia; lymphoma and 
carcinoma. They suggested that these findings might be applicable to 
the detection of neoplastic tissues in less accessible sites. 
Dun-Bing Chang et al (1994)22 evaluated the efficacy of CDUS in 
detecting possible differences in blood flow pattern between 
malignant and benign cervical lymph nodes. They found sensitivity 
of 91% specificity of 63% of colour flow pattern alone in the 
diagnosis of malignant lymph nodes and sensitivity of 81% and 
specificity of 75% on the basis of intranodal vascular resistance. 
Min Yun Choi et al (1995)25 determined the value of Doppler 
spectral waveform to distinguish between benign and malignant 
lymph nodes. They found that lymph nodes involved by metastases 
showed a characteristic high RI(>1.0) and PI (>1.5) ,whereas lymph 
nodes involved by benign processes showed a low RI (<0.8) and low 
PI (<1.5).They suggested  that superficial lymphadenopathy due to 
benign and malignant diseases can be distinguished with a high 
degree of accuracy by means of spectral waveform analysis. 
Dong Gyu Na et al (1997)53 evaluated the usefulness of CDUS in 
differentiating benign from malignant cervical lymphadenopathy. 
Benign nodes showed central hilar vascularity in 94% of cases and 
abnormal flow pattern (absent or peripheral) was found in 98% of 
malignant and all tuberculous nodes. They established cut-off value 
of 0.8 for RI and 1.5 for PI that was 100% specific for malignancy. 
They concluded that CDUS combined with analysis of spectral 
waveform was useful in differentiating benign from malignant 
cervical lymphadenopathy. 
Yoshiko Ariji et al (1998)16  evaluated the usefulness of Power 
Doppler sonography in differentiating metastatic from non-metastatic 
cervical lymph nodes in patients with head and neck cancer. They 
concluded that the power Doppler criteria of no hilar flow, peripheral 
parenchymal nodal flow, and a transverse to longitudinal ratio of 
more than 0.65 together constitute a powerful tool for depicting 
metastatic lymph nodes in patients with cancer. 
H-J Steinkamp et al (1998)68   evaluated reactive as well as 
metastatic and malignant cervical lymph nodes by CDUS with 
quantification of intensity of the perfusion. Reactive nodes showed 
intense hilar perfusion, metastatic nodes showed mainly peripheral 
flow and malignant node due to lymphoma showed intense hilar as 
well as peripheral flow. They concluded peripheral pattern may 
provide additional information in the differential diagnosis of 
cervical lymphadenopathy. 
Zehra Hilal Adibellia et al (1998)1 evaluated the efficacy of CDUS 
B-mode ultrasonography to differentiate between benign and 
malignant cervical lymph nodes. They concluded that both are of 
limited value in differentiating benign from malignant nodes .and 
cannot replace biopsy.  
Chih-Hsiu Wu et al (1998)72 used 2-D & 3-D PDUS in classifying 
the vascular patterns in cervical lymphadenopathy .they found that 
benign lymph nodes had a vascular (89%) and hilar (83%) flow, 
whereas malignant modes had spotted (72%), peripheral (60%), and 
mixed type (80%) of vascular patterns.(B-26-459002) 
Anil T.Ahuja et al (1999)13   studied colour duplex sonographic 
changes in successfully treated metastatic nodes from nasopharyngeal 
carcinoma in fourteen patients. The features studied included 
distribution of intra nodal vascularity, resistive and Pulsatility 
indexes, and peak systolic velocity. The majority (90%) of malignant 
nodes from nasopharyngeal carcinoma have an increased central and 
peripheral vascularity, a high resistive index (0.8), and a high 
Pulsatility index (1.8). After radiation therapy to the nodes, a 
reduction in intranodal vascularity and a statistically significant 
reduction in the resistive index (0.58 to 0.59) and Pulsatility index 
(0.91 to 0.93) are found. They suggested that after radiation therapy 
for malignant nodes in nasopharyngeal carcinoma, a reduction in 
intranodal vascularity is found, and the resistive and Pulsatility 
indexes may return to benign parameters as early as 8 weeks after 
completion of treatment.  
Chiung-Nien Chen et al (2000)23 investigated the clinical usefulness 
of the colour Doppler vascularity index (CDVI) in patients with 
colon cancer before surgery. Forty-four patients with sonographically 
visible tumour mass of colon cancer were investigated. The CDVI 
was significantly higher in the patients with lymph node metastases 
and vascular invasion than in those without such metastases and 
invasion (P=0.006 and P=0.0098, respectively).Moreover, in patients 
with a high CDVI (>15%) and positive vascular invasion, survival 
was significantly poorer than in those with low CDVI (<15%) and 
negative invasion (P=0.0037 and 0.0039, respectively). According to 
the mode of recurrence in 36 patients who underwent curative 
resection, the frequency of the distant organ recurrence was 
significantly higher in the high CDVI group (40%) than in the low 
CDVI group (0%). The CDVI is a good preoperative indicator of 
recurrence and patient survival in colon cancer. Thus, the CDVI may 
be helpful in stratifying patients for adjuvant therapy. 
Toru Chikui et al (2000)24 determined the most predictive 
sonographic features in cervical lymph nodes in patients with head & 
neck cancer by analyzing grey scale and power Doppler sonograms. 
They found that although multivariate analysis did not indicate any 
significant contribution of colour flow criteria for predicting 
metastatic nodes, the colour flow criteria appeared to improve the 
overall diagnostic accuracy for the less experienced observer. 
HO S.S.Y. et al (2000)39   performed colour Doppler sonography of 
malignant lymph nodes in patient with NHL and nasopharyngeal 
carcinoma in 60 nodes in 34 patients. They found significant 
difference in Doppler waveform between malignant nodes affected by 
lymphoma or nasopharyngeal carcinoma, suggesting that further 
differentiation of malignant nodes may be possible. 
Tse Yang et al, (2000)75 documented differences in colour Doppler 
flow and gray-scale Ultrasonographic (US) features between benign 
and malignant axillary lymph nodes in women with primary breast 
cancer. The longitudinal-transverse axis ratio and hilar status on 
colour Doppler flow and gray-scale US images were prospectively 
studied for each of 145 axillary nodes in 135 women (74 palpable 
nodes in 69 women, 71 non palpable nodes in 66 women) with 
primary breast cancer. They concluded that Colour Doppler flow and 
gray-scale US features applicable to the identification of disease in 
palpable axillary nodes in patients with breast cancer are not 
applicable to non palpable nodes. 
Jörg D. Moritz et al (2000)48    determined whether contrast-
enhanced colour Doppler sonography can differentiate benign from 
malignant enlarged cervical lymph nodes in head and neck tumours. 
Ninety-four enlarged lymph nodes in 39 adult patients were 
examined. With contrast-enhanced colour Doppler sonography, 
characteristic configurations were identified: hilar vessels with 
branching indicated lymphadenitis and predominantly peripheral 
vessels indicated metastases.  
 They concluded that enlarged lymph nodes can be characterized 
as metastatic or inflammatory with high diagnostic accuracy on the 
basis of their vascular architecture as seen on contrast-enhanced 
colour Doppler sonography. 
Hiroshi Yusa et al (2000)81 studied the usefulness of grey scale and 
CDUS for assessment for response to radio chemotherapy of 
metastatic cervical lymph nodes in head & neck cancer. Complete 
response nodes demonstrated hypo echoic internal echo and internal 
blood perfusion before radio chemotherapy. Most poor response 
nodes showed peripheral blood perfusion and avascular pattern. 
Complete response nodes showed a significant reduction in their 
maximum and minimum diameter. 
Anil T. Ahuja et al (2001)5 identified the parameters used in 
Doppler sonography in differentiating benign from metastatic neck 
nodes. They found that metastatic nodes tend to have higher 
intranodal vascular resistance than reactive nodes, but there was 
considerable overlap of resistance parameter between two groups. 
Metastatic nodes showed peripheral vascularity; majority of reactive 
nodes showed hilar vascularity. They concluded that the distribution 
of intranodal vascularity appears to be more useful than RI or PI in 
differentiating benign and from malignant cervical lymphadenopathy. 
Anil Ahuja et al (2001)6  evaluated the tuberculous lymphadenitis 
and metastatic nodes from nasopharyngeal carcinoma by power 
Doppler sonography. The intranodal vascular appearances of 
tuberculous neck nodes were compared with benign reactive neck 
nodes and metastatic nodes from nasopharyngeal carcinoma. 
 They found that the intranodal vascular distribution in 
tuberculous nodes was varied and simulated both benign and 
malignant disease. Avascularity of nodes and displacement of hilar 
vascularity were frequent in tuberculous nodes. They also found that 
Metastatic nodes from nasopharyngeal carcinoma had a higher 
vascular resistance than did tuberculous nodes and tuberculous nodes 
had a higher vascular resistance than did reactive nodes. 
Anil Ahuja et al (2001)11 investigated the difference in the nodal 
hilus evaluated by gray scale and power Doppler sonography. They 
included One hundred ninety-two patients with proven cervical 
lymphadenopathy in the study (metastases, n = 118; tuberculosis, n = 
56; and lymphoma, n = 18). Lymph nodes were evaluated by gray 
scale sonography for the echogenic hilus and power Doppler 
sonography for hilar vascularity. They found hilar vascularity even 
though the lymph node did not show an echogenic hilus on gray scale 
sonography. They concluded that gray scale and Doppler sonography 
show different aspects of the hilus, and the absence of the hilus on 
gray scale sonography does not necessarily imply an associated 
absence of hilar vascularity. 
Takako Shirakawa et al (2001)65  used colour/power Doppler 
sonography in differential diagnosis of superficial lymphadenopathy. 
They found extra hilar vessels in 85.4% of metastatic, 40.5% of 
lymphomatous and 7.7% of benign nodes regardless of node size. The 
mean RI & PI values of metastatic nodes were higher than those of 
benign nodes with lymphomatous nodes had intermediate values. 
They concluded that PI >1.3 & RI>0.72 suggested malignancy as 
measured from any vessel. 
Misa Sumi et al (2001)69  compared the ability of sonography and CT 
to differentiate benign from malignant cervical lymph nodes by 
analyzing 209 cervical nodes (102 metastatic and 107 non metastatic) 
from 62 patients with head and neck cancer. They concluded that 
sonography performed significantly better than CT in depicting 
cervical metastatic nodes. 
Koichi Yonetsu et al (2001)80  tested whether the combined use of 
size criteria and Doppler Sonographic findings would improve the 
predictive ability for metastatic cervical nodes. They analyzed 338 
histologically proved cervical lymph nodes (108 metastatic and 230 
non metastatic) in 73 patients with head and neck cancer. The 
combined criteria yielded high sensitivities (89%) and specificities 
(94%).They concluded that hilar blood flow information obtained by 
Doppler sonography significantly improves diagnostic accuracy for 
the detection of nodes metastatic from head and neck squamous cell 
carcinoma. 
Tatsuya Sakaguchi et al (2001)62  differentiated reactive small round 
lymph nodes (SRLNs) from metastases by power Doppler 
ultrasonography (PD-US) and contrast-enhanced CT (CE-CT) 
performed in 99 cervical lymph nodes (LNs) with a maximum 
diameter of 1.5 cm or smaller and maximum longitudinal/transverse 
ratio of 1.5 or smaller in 76 patients with head and neck cancer. They 
concluded vascular patterns evaluated with PD-US and enhancement 
patterns on CE-CT can characterize SRLNs. For an avascular pattern 
on PD-US, information on CE-CT results can significantly increase 
the accuracy of characterization. 
Francesco Giovagnorio et al (2002)34  performed a retrospective 
study to document the sonographic and colour Doppler characteristics 
of lymphomatous superficial lymph nodes in 130 individuals who 
underwent sonography, colour Doppler imaging, fine-needle 
aspiration biopsy, and surgical removal of the nodes with the final 
diagnosis of lymphoma (87) and chronic adenitis (43). They 
concluded that the presence of peripheral sub capsular vessels, which 
is typical of metastasis, is definitely rare in lymphoma (with the 
possible exception of the uncommon subtypes of high-grade 
lymphomas). 
Ying et al (2002)76 investigated the racial difference in gray scale 
and power Doppler sonography of cervical lymph nodes between 
white and Chinese subjects. Lymph nodes were evaluated for their 
number, size, site, echogenic hilus, and vascular pattern, degree of 
vascularity, blood flow velocity, and vascular resistance in 20 
healthy white and 20 healthy Chinese subjects. They found that there 
were no significant differences in the number, size, and distribution 
of the lymph nodes between the 2 populations. They also found that 
there was no significant difference in the gray scale and vascular 
features of cervical nodes between white and Chinese subjects. This 
study concluded that results on power Doppler and gray scale 
sonographic assessment of cervical Lymphadenopathy reported in 
previous studies may be applicable in both populations. 
Monika-Hildegard Schmid-Wendtner et al (2002)64  evaluated 
administration of a D-galactose–based signal enhancer in colour 
Doppler sonography (CDS) for better detection of vascularity 
patterns, to differentiate malignant from benign lymph nodes in 
patients with cutaneous melanomas with comparison of B-mode 
sonography, native CDS, and signal-enhanced CDS. They concluded 
that administration of a D-galactose–based signal enhancer for CDS 
in patients with cutaneous melanomas can help to differentiate 
malignant from reactive lymph nodes, hematomas, or seromas. 
Sato Eida et al (2003)31 used a   combination of contrast-enhanced 
helical CT and Doppler sonography to monitor the necks of 58 
patients with initial clinical N0 stage neck disease. The combined 
criteria were effective in revealing 26 (87%) nodes, yielding 87% 
sensitivity, 100% specificity, and 100% positive and 99% negative 
predictive values. The independent use of one of these techniques 
alone resulted in low (67%) or moderate (87%) positive predictive 
values for sonography and CT, respectively. They concluded that the 
combination of contrast-enhanced helical CT and Doppler 
sonography is useful for the follow-up study of clinical N0 stage 
neck disease. 
Gernot Schulte-Altedorneburga et al (2003)14 used contrast agent 
with CDUS & PDUS to improve their diagnostic accuracy in 
differentiating benign and malignant superficial lymph node 
enlargement. They concluded that use of contrast agent seems not to 
improve the diagnostic accuracy of CDUS & PDUS compared with 
native colour mode studies. 
Michael Ying et al (2004)79 evaluated the accuracy of power 
Doppler Sonographic features in differentiating cervical 
lymphadenopathy in different diseases, in 270 patients by using 
FNAC or Excisional biopsy for confirmation. They found that 
vascular pattern  was more useful in differentiating reactive from 
malignant nodes with a sensitivity of 88% and specificity of 
100%.RI>0.8 &PI > 1.5 was more accurate  for metastatic nodes with 
a accuracy of 65% & 77% respectively. 
Anil T. Ahuja et al (2004)10 compared the performance of colour 
Doppler, power Doppler and 3-D power Doppler sonography in the 
assessment of vascular pattern and vessel displacement of cervical 
lymph nodes. Colour Doppler, power Doppler and 3-D power Doppler 
sonograms of 145 cervical nodes were reviewed (metastases n  = 60, 
lymphoma n  = 30, tuberculosis n  = 23, reactive n  = 25, Kimura 
disease n  = 7). Results showed that there was a high level of 
agreement between CDS and PDS in assessment of vascular patterns, 
whereas the level of agreement between CDS and 3-D PDS and 
between PDS and 3-D PDS was low. There was a high level of 
agreement in the assessment of displacement of hilar vascularity 
among the three imaging modes. In the assessment of vascular 
patterns of cervical lymphadenopathy, CDS and PDS have a similar 
performance. However, accurate assessment of the vascular pattern of 
cervical nodes may be difficult using 3-D PDS. In the assessment of 
displacement of hilar vascularity, the performances of CDS, PDS and 
3-D PDS are similar. 
Özerk ömür ökten (2004)54 evaluated the value of the gray-scale, 
colour Doppler and power Doppler ultrasonography in the differential 
diagnosis of lymphomatous superficial lymph node enlargements. 
The study group consisted of 33 males and 16 female. During the 
CDUS and PDUS examination, they classified the nodes into 3 
patterns: type I, “hilar normal”; type II, “hilar activated”; and type 
III, “peripheral”. Pulsatility (PI) and resistivity RI) indexes were 
calculated using CDUS. When clinical data and histopathological 
findings were combined, 27 subjects were diagnosed as lymphoma, 
and 22 cases were classified as lymphadenitis. Semi quantitative 
CDUS parameters are not valuable in the differential diagnosis of 
lymphomatous superficial lymph node pathologies. Qualitative 
GSUSG and PDUSG features, may be used as an alternative work-up 
to cytological studies in patients in whom diagnostic surgical 
procedures cannot be performed. 
Huang Y et al (2008)40 determined whether the resistive index (RI) 
ratio based on high-resolution spectral Doppler sonography would be 
useful in the differential diagnosis of small inflammatory and 
metastatic lymph nodes in rabbit models. They evaluated the sizes, 
long-/short-axis ratios, and RI ratios (defined as the value of the 
peripheral RI relative to the central RI) of the nodes were evaluated 
with sonography and then compared with the histopathologic 
findings. They found no statistical differences were found between 
the volumes and the long-/short-axis ratios of 15 inflammatory and 
14 metastatic lymph nodes. On spectral Doppler sonography, the RI 
ratio was higher in the metastatic lymph nodes than in the 
inflammatory lymph nodes. They concluded that RI ratio changes 
based on high-resolution spectral Doppler sonography are associated 
with histopathologic changes of metastatic and inflammatory lymph 
nodes during the initial stage in rabbits. 
Anil Ahuja et al (2008)12  evaluated different causes of lymph node 
enlargement by ultrasound. They noted the following observations. 
On ultrasound; grey scale sonography helps to evaluate nodal 
morphology, whilst power Doppler sonography is used to assess the 
vascular pattern. Grey scale sonographic features that help to identify 
metastatic and lymphomatous lymph nodes include size, shape and 
internal architecture (loss of hilar architecture, presence of 
intranodal necrosis and calcification). Soft tissue edema and nodal 
matting are additional grey scale features seen in tuberculous nodes 
or in nodes that have been previously irradiated. Power Doppler 
sonography evaluates the vascular pattern of nodes and helps to 
identify the malignant nodes. In addition, serial monitoring of nodal 
size and vascularity are useful features in the assessment of treatment 
response. 
Dangore et al (2008)28 evaluated the efficacy of colour Doppler 
ultrasound (CDUS) to differentiate between benign and malignant 
cervical lymph nodes. CDUS was performed for 168 cervical lymph 
nodes in these 100 patients. Histopathological confirmations were 
obtained by fine needle aspiration biopsy and/or excisional biopsy. 
They compared the clinical features, CDUS features and 
cytological/histological features of enlarged cervical lymph nodes. 
Correlation of patterns of colour Doppler flow signals with 
pathological diagnosis showed that central flow for benign nodes and 
peripheral flow for malignant nodes were highly significant 
parameters. They found that CDUS has a higher specificity than 
clinical evaluation, being 94.28% and 58.76%, respectively. 
Accuracy of the CDUS examination was also definitely higher than 
clinical evaluation at 92.85% and 63.67%, respectively. 
Suwarna Dangore-Khasbage et al (2009)29 studied the utility of 
CDUS in evaluating the status of cervical lymph nodes in 30 oral 
cancer patients. They used intranodal vascular flow pattern and 
vascular resistance as the key CDUS features to differentiate between 
metastatic and reactive cervical lymph nodes. They found CDUS to 
be highly significant with a sensitivity of 92.90% and a specificity of 
84.21% after comparing the CDUS findings with histopathological 
findings. 
 
 
               
 
 
      
 
 
 
 
 
           
 
MATERIAL AND METHODS 
 
 This study was conducted in the Department of Oral Medicine 
and Radiology, Tamil Nadu Government dental college and hospital, 
Chennai-3; Barnard Institute of Radiology, Madras Medical College, 
Chennai-3; Goschen Institute of Pathology, Madras Medical College, 
Chennai-3.This study was carried out after obtaining approval from 
Institutional Ethical Committee and informed written consent from 
each patient. Study comprised 80 Adult Subjects with clinically and 
histopathologically diagnosed Oral cancer of either gender with age 
range of 20-60 years. All the findings were recorded in a structured 
Performa designed for the purpose of this study.  
 To avoid over-diagnosis of lymph nodes in patients with oral 
cancer, study was divided in two groups based on clinical criteria. 
Group-I included 40 patients with clinically suspected Metastatic 
cervical lymph nodes, Group-II included 40 patients with clinically 
suspected Reactive Cervical lymph nodes. Inclusion criteria were 
patients with oral cancer diagnosed on the basis of thorough history 
and clinical examination followed by histopathological confirmation. 
 Exclusion criteria were those Patients with acute cervical 
lymph node enlargement due to infections; with malignancies of 
lymph nodes like Lymphoma, lymphocytic leukaemia; with 
generalized lymphadenopathy; in cases where FNAC was 
inconclusive.  
 The clinical stage and location of primary tumour was 
determined according to the recommendations of American Joint 
Committee on Cancer Staging.15 (Figure-2, 3) 
 Initially, the cervical lymph nodes were assessed based on 
clinical criteria to differentiate metastatic lymph nodes from reactive 
nodes (Figure-4). Clinical criteria used for differentiating metastatic 
lymph nodes were (I) lymph node size larger than 1 cm in diameter, 
(ii) a hard, and stony hard in consistency, (iii) fixation to underlying 
structures.33 ,  58  Based on these criteria 2 groups were formed: Group-
I of 40 patients with clinically suspected Metastatic Cervical lymph 
nodes and Group-II of 40 patients of clinically suspected Reactive 
lymph nodes. 
 After getting the informed consent, the same patients with oral 
cancer were evaluated with Colour Doppler Ultrasound (CDUS) for 
cervical lymph node involvement (Figure-6). The CDUS was 
performed by an experienced radiologist by using Linear Multi-
frequency Transducer with range of 5MHz-13MHz (ACUSON 
ANTARES MODEL PREMIUM EDITION, SIEMENES 
MEDICAL).The radiologist had not been given any clinical data or 
pathological diagnosis in any of the cases and the findings were 
recorded in a tabular format. Initially adequate observation of the 
lymph node with grey scale sonography was done followed by colour 
Doppler evaluation.  
 Different criteria considered in CDUS of the lymph nodes were 
colour flow signals and intranodal vascular resistance (Pulsatility 
Index and Resistivity Index).  
 The vascular pattern of the enlarged lymph nodes was 
classified into the following four groups, according to the location of 
the vascularity: 
1. Peripheral (Figure-7) 
2. Mixed (Figure-8) 
3. No flow (Figure-9)  
4. Central (Figure-10) 
 The presence of blood flow signals in the centre of node 
suggests that the node is reactive. The presence of peripheral, mixed 
or no flow suggests a metastatic nature.  
 On-board software was used for the evaluation of the vascular 
resistance, Resistive index (RI) and Pulsatility index (PI), peak 
systolic velocity and end diastolic velocity of lymph nodes. The 
presence of high intranodal vascular resistance had been used as a 
key feature to differentiate metastatic from reactive nodes. 
Metastatic nodes will have high PI and RI values as compared to low 
PI and RI values for Reactive nodes. Cut-off values used for PI was 
1.5 and for RI was 0.7 as suggested by Wu et al.73 PI and RI more 
than cut-off values suggested metastatic node whereas PI and RI less 
than cut-off suggested a reactive node.   
 Cytological diagnosis of the same lymph nodes was made from 
FNAC or ultrasound guided FNAC with patient in supine position. 
(Figure-12) Ultrasound guided FNAC was used to guide needle at 
proper location in the lymph node, in cases where unguided FNAC 
was not possible like in deep seated node, in obese patients due to 
thick overlying tissue. In our study 5 patients out of 80 patients 
underwent US guided FNAC. 
 FNAC was used as a standard, to confirm the etiology of the 
lymph node enlargement. Each node was cytologically determined to 
be metastatic or reactive. In patients with many lymph nodes 
belonging to the same group of lymph nodes with similar CDUS  
appearance, the most prominent and accessible node was subjected to 
FNAC and its cytopathological appearance was considered for 
correlation with CDUS features of all lymph nodes from the same 
group. In all oral cancer patients, FNAC was suggestive of either 
Metastatic (Figure-13) or Reactive (Figure-14) lymph node 
involvement. 
 All aspirated material from lymph nodes were smeared on two 
slides. One slide was fixed in Isopropyl Alcohol (70%-90%) for 20-
30 minutes followed by H & E staining; Second slide was fixed in 
95.6% methanol for MGG (May-Grunewald-Giemsa solution) staining 
for more nuclear details. Each lymph node was evaluated 
pathologically with an emphasis on the presence or absence of 
dysplastic cells in cytology. An experienced pathologist performed 
the cytological evaluation of the cervical lymph nodes. A 
comparative study was done between the clinical features, CDUS and 
the cytological features of cervical lymph nodes. Chi-Square Test 
(SPSS 15.0 version) was used to evaluate the significance of the 
parameters used between the two study groups. 
INSTRUMENTATION 
Clinical examination Armamentarium (Figure-1) 
• Disposable gloves 
• Face mask 
• Patient’s apron 
• Stainless steel tray 
• Mouth mirror, explorer and tweezer for each patient. 
• Gauze 
• Retractor 
• Nikon Coolpix S3000 Digital camera (12 megapixels) to 
capture images. 
Colour Doppler ultrasound examination Armamentarium (Figure-
5) 
• Ultrasound machine (Acuson Antares Premium Edition-Siemens 
Medical) 
• VFX 13-5(Multi-D) Ultrasound Probe  
• DIAMED Ultrasound Gel  
Fine Needle Aspiration Cytology examination Armamentarium 
(Figure-11) 
• 5 ml. syringe with 22 gauge needle for taking FNA samples.  
• Glass Slides 
• 70-90% Isopropyl Alcohol in Coplin Jar  
• 95.6% Methanol in Coplin Jar  
• H & E stain  
• MGG stain  
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1. I have been informed to my satisfaction about the purpose of the study and study 
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4. I agree to report to the doctor for a regular follow-up as and when required for 
the research. 
5. I hereby give permission to use my medical records for research purpose.  
6. I have been told that the investigating doctor and institution will keep my identity 
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DIAGNOSTIC ACCURACY OF COLOUR DOPPLER 
ULTRASONOGRAPHY IN EVALUATION OF CERVICAL LYMPH 
NODES IN ORAL CANCER PATIENTS 
 
DEPARTMENT OF ORAL MEDICINE AND RADIOLOGY 
TAMILNADU GOVERNMENT DENTAL COLLEGE AND HOSPITAL 
CHENNAI – 600003 
 
 PROFORMA 
 
 
Date:    Dental O.P. No:    Serial No: 
 
Name:                                                                Age / Sex: 
 
Address:                                                             Tel. no:    
 
Occupation:    Income: 
 
Chief Complaints with Duration: 
 
  
Past Medical history: 
      1. Epilepsy                                                                          6.Hypertension 
      2. Tuberculosis                                                                   7.Asthama 
      3. Jaundice                                                                          8.Diabetes Mellitus 
      4. Pregnancy / Lactation                                                     9.Cardiac diseases 
      5. Prolonged medication                                                    10.Others 
Past Surgical History:                                                                                                
 
Dental history: 
 
Personal History: 
 
GENERAL EXAMINATION: 
 
Nutritional Status:   Good/ Moderate / Poor  
 
Anemia:                                               Loss of Weight: 
 
HEAD AND NECK EXAMINATION:    
 
 
Extra – Oral Examination: 
CERVICAL LYMPH NODE EXAMINATION: 
 
A.INSPECTION:                                                                                                         
 
   1. Site                                    
   
   2. Number:                                                            Size: 
    
B. PALPATION:                              
 
   1. Local Temperature:                                       2.Number 
 
   3. Tenderness:                                           
 
   4. Consistency: Firm/Hard/Stony Hard  
                          Indurated or Variable 
     
   5. Fixity to Surrounding Structures: 
    
    Intra-Oral Examination: 
 
    Oral hygiene: Poor /Fair /Good 
    Mouth Opening:  
    Teeth:                  Mobile:                                      Pain:                                                               
                                 Lost:                                          Irritation: 
   Difficulty in mastication:  
    
   Dysphagia:                                                 Loss of Taste:  
 
   Tongue Protrusion: 
  
   Numbness /Tingling: 
   Others: 
 
  Type of Lesion: 
 
  Nodular /Growth / Gangrenous / Ulcer / Ulcerated growth / Papillary / Induration 
   
  Fissured / Unicentric / Multicentric / Others 
 
  Extension: 
 
  Size: 
  Description:   
 
Associated /Preexisting / Precancerous conditions / Lesion: 
 
Leukoplakia                          Oral Sub mucous Fibrosis         Lichen planus 
Others: 
 
RADIOGRAPHIC FINDINGS: 
Bone Involvement: Erosion / Infiltration / Intra Bony / Pathological Fracture 
Other: 
 
DIAGNOSIS: 
 
CLINICAL STAGING: T…………………N……………M………………….. 
 
INVESTIGATIONS: 
 1. Laboratory Investigations: 
 
a. Blood  :  TC                DC                                                     
               Hb%            ESR          
               Bleeding Time                                                    Clotting Time 
               Peripheral Smear: 
 
b. Urine  : Sugar     : 
                         Albumin: 
 
2. Colour Doppler Ultrasound finding: 
 
 
 
3. FNAC finding: 
 
 
 
Signature: 
 
Date: 
 
Time: 
PHOTOGRAPHS 
CLINICAL EXAMINATION 
  
Figure-1.Armamentarium 
 
Figure-2 Case-1 Oral cancer involving Right buccal mucosa  
Figure-3 Case-2 Oral cancer involving Left retromolar trigone 
 
 Figure-4.Evaluation of cervical node by clinical palpation 
COLOUR DOPPLER ULTRASONOGRPHY 
 
Figure-5 Colour Doppler Ultrasound Unit (Acuson Antares Premium 
Edition, Siemens Medical) 
 Figure-6.Evaluation of left submandibular lymph node in the oblique 
plane with the use of transducer 
 
 
Figure-7.Metastatic Lymph node with Peripheral flow pattern (L) 
Spectral wave form pattern (C) and Vascular indices values (R) (Case-
1) 
  
Figure-8.Metastatic Lymph node with Mixed flow pattern (L) Spectral 
wave form pattern (C) and Vascular indices values (R) 
 
Figure-9.Metastatic Lymph node with No flow   
  
 
 
 
 
 
 
 
Figure-10.Reactive Lymph node with central flow pattern (L) Spectral 
wave form pattern (C) and Vascular indices values (R) (Case-2) 
FINE NEEDLE ASPIRATION CYTOLOGY (FNAC) 
 
Figure-11.Armamentarium 
 
  
Figure-12.Collection of aspirates from right submandibular lymph node 
for FNAC in Supine position 
 
 
Figure-13.Photomicrograph showing metastatic lymph node with 
deposits of malignant squamous cells at multiple sites and rudimentary 
lymphoid tissue in sub-capsular area (H & E x10) (Case-1) 
  
 
 
.  
Figure-14.Photomicrograph showing reactive lymph node with 
centroblasts, centrocytes and small lymphocytes with nuclear fragments 
(MGG High Power) (Case-2) 
 
 
 
 
 
 
 
 
TABLES AND CHARTS 
Table–1. Gender wise distribution of study population( 80 patients). 
Gender Group-I Group-II Total P-value 
Male 26(32.5%) 24(30%) 50(62.5%) 
0.644 Female 14(17.5%) 16(20%) 30(37.5%) 
Total 40 40 80 
 
Table–2.Site-wise distribution of oral cancer 
Site of cancer 
in oral cavity 
Group-I 
 
Group-II 
 
Total P-Value 
Buccal mucosa 4(5%) 20(25%) 24(30%) 
0.003** 
Tongue 10(12.5%) 5(6.25%) 15(18.75%) 
Alveolus 15(18.75%) 7(8.7%) 22(27.5%) 
Oropharynx 3(3.75%) 1(1.25%) 4(5%) 
Gingivo buccal 
sulcus 
- 3(3.75%) 3(3.75%) 
Retromolar 
trigone 
2(2.5%) 2(2.5%) 4(5%) 
Palate 4(5%) 2(2.5%) 6(7.5%) 
Floor of mouth 2(2.5%) 0 2(2.5%) 
Total 40 40 80 
 
Table–3.  Site-wise distribution of oral cancer with gender 
correlation. 
Site of cancer 
in oral cavity Male Female Total P-value
Buccal mucosa 15(18.75%) 9(11.25%) 24(30%) 
0.500 
Tongue 11(13.75%) 4(5%) 15(18.75%) 
Alveolus 10(12.5%) 12(15%) 22(27.5%) 
Oropharynx 3(3.75%) 1(1.25%) 4(5%) 
Gingivo 
buccal sulcus 2(2.5%) 1(1.25%) 3(3.75%) 
Retromolar 
trigone 4(5%) 0 4(5%) 
Palate 4(5%) 2(2.5%) 6(7.5%) 
Floor of 
mouth 1(1.25%) 1(1.25%) 2(2.5%) 
Total 50(62.5%) 30(37.5%) 80 
Table–4.Group-wise distribution of TNM staging of oral cancer 
TNM staging 
Groups 
Total P- Value 
Group-I Group-II 
T1 0 5(6.25%) 5 (6.25%) 
<0.001** 
T2 5(6.25%) 16(20%) 21(26.25%) 
T3 2(2.5%) 5(6.25%) 7(8.75%) 
T4 33(41.25%) 14(17.5%) 47(58.75%) 
Total 40 40 80 
 
Table–5.  Site-wise distribution of oral cancer with TNM staging. 
Site of cancer 
in oral cavity 
TNM staging 
 
Total 
 
P- 
Value 
T1 T2 T3 T4 
Buccal mucosa 2(2.5%) 12(15%) 3(3.75%) 7(8.75%) 24 
 
 
 
 
 
<0.001**
Tongue 0 1(1.25%) 0 14(17.5%) 15 
Alveolus 1(1.25%) 0 1(1.25%) 20(25%) 22 
Oropharynx 0 1(1.25%) 2(2.5%) 1(1.25%) 04 
Gingivo 
buccal sulcus 
2(2.5%) 1(1.25%) 0 0 03 
Retro molar 
trigone 
0 3(3.75%) 0 1(1.25%) 04 
Palate 0 3(3.75%) 1(1.25%) 2(2.5%) 06 
Floor of mouth 0 0 0 2(2.5%) 02 
Total 5 (6.25%) 21(26.25%) 7(8.75%) 47(58.75%) 80 
 
Table –6.Gender-wise distribution of TNM staging of oral cancer  
Gender 
TNM staging 
Total P-valueT1 T2 T3 T4 
Male 3(3.75%) 16(20%) 4(5%) 27(33.75%) 50(62.5%)
0.514Female 2(2.5%) 5 (6.25%) 3(3.75%) 20(25%) 30(37.5%)
Total 5(6.25%) 21(26.25%) 7(8.75%) 47(58.75%) 80 
 
Table–7.Gender-wise distribution of cervical lymph nodes in 80 
patients with oral cancer. 
 
Gender Group-I Group-II Total no. of lymph nodes 
P-value 
 
Male 44(39.3%) 26(23.2%) 70(62.5%) 
0.398 Female 23(20.6%) 19(16.9% ) 42(37.5%) 
Total 67(59.9%) 45(40.1%) 112 
 
 
Table-8.Comparison of clinical examination Vs FNAC of cervical 
lymph nodes in 80 oral cancer patients (112 lymph nodes) 
Types of 
lymph nodes 
Clinical 
suspicion 
Fine needle 
Aspiration 
Findings (FNAC)
 
P-value 
 
Metastatic 
nodes 67(59.9%) 84(75%) 
0.010** Reactive 
nodes 45(40.1%) 28(25%) 
Total 112 112 
 
 
 
 
Table –9.Total cervical lymph nodes evaluated by CDUS in 80 
patients with oral cancer  
Groups 
Clinically 
evaluated 
nodes 
Additional 
nodes evaluated  
by CDUS 
Total 
nodes 
evaluated  
by CDUS 
P-
Value 
 
Group-I 67(51%) 17(13%) 84(64%) 
0.013* Group-II 45(34.5%) 2(1.5%) 47(36%) 
Total 112(85.5%) 19(14.5%) 131 
      
 
Table–10.Level-wise distribution cervical lymph nodes by CDUS 
Levels of cervical 
lymph nodes Group-I Group-II Total 
P-
value
I 67(51%) 45(34.4%) 112(85.4%) 
0.086
II 12(9.1%) 2(1.6%) 14(10.7%) 
III 05(3.9%) 0 5(3.9%) 
Total 84(64%) 47(36%) 131 
 
 
 
 
 
Table –11.Correlation of Colour Doppler flow patterns of in 131 
lymph nodes in 80 oral cancer patients 
Colour Doppler 
Flow 
Group-I Group-II Total P-value
Central 6(4.6%) 29(22.1%) 35(26.7%) 
<0.001**
Peripheral 64(48.8%) 17(13%) 81(61.8%) 
Mixed 11(8.3%) 1(0.9%) 12(9.2%) 
No flow 3(2.3%) 0 3(2.3%) 
Total 84(64%) 47(36%) 131 
 
Table-12. Mean values of Intranodal vascular resistance in metastatic 
and reactive lymph nodes 
Vascular 
indices 
Metastatic nodes Reactive nodes 
P-value 
Mean SD Mean SD 
PI 2.33 0.78 0.92 0.32 <0.001**
RI 0.83 0.12 0.52 0.12 <0.001**
            
              
 
 
Table – 13.Correlation of vascular indices of CDUS in131 lymph 
nodes in 80 oral cancer patients 
Vascular 
indices Group-I Group-II Total P-value 
PI > 1.5 
RI > 0.7 
73(55.7%) 10(7.7%) 83(63.4%) 
<0.001** PI < 1.5 
RI < 0.7 
11(8.3%) 37 (28.3%) 48(36.6%) 
Total 84(64%) 47(36%) 131 
           
Table-14.Comparison of Colour Doppler flow pattern Vs FNAC in 
clinically evaluated cervical lymph nodes in   oral cancer                
patients (112 lymph nodes) 
Types of 
lymph nodes 
CDUS Fine needle 
Aspiration 
Findings 
(FNAC) 
P-value 
Flow pattern 
(A) 
Vascular indices 
(B) (A) (B) 
Metastatic 
nodes 
78(69.6%) 67(59.8%) 84(75%) 
0.293 0.007** Reactive 
nodes 
34 (30.4%) 45(40.1%) 28(25%) 
Total 112 112 112 
 
 
Table-15.Comparison of Colour Doppler findings Vs Cytological 
examination of Cervical lymph nodes in 80 oral cancer patients (131 
lymph nodes) 
 
Types of 
lymph nodes 
CDUS Fine needle 
aspiration 
Findings  
(FNAC) 
 
P-value Flow pattern
(A) 
Vascular 
Indices (B) (A) (B) 
Metastatic 
nodes 
96(73.3%) 83(63.4%) 102(77.9%) 
0.388 0.010** 
Reactive 
nodes 
 
35(26.7%) 
 
48(36.6%) 
 
29(22.1%) 
 
Total 
 
131 
 
131 
 
131 
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RESULTS AND ANALYSIS  
 This study enrolled 80 subjects with oral cancer comprising 
two groups. Group-I included 40 patients with clinically suspected 
Metastatic Cervical lymph nodes, Group-II included 40 patients with 
clinically suspected Reactive Cervical lymph nodes based on the 
clinical criteria, with age range of 20-60 years either sex. The 
patients were selected from the Department of Oral Medicine and 
Radiology, Tamilnadu Government Dental College & Hospital, 
Chennai-600003. Group-I included 26 (65%) male (age range 32-60 
years) and 14(35%) females (age range 25-60years). Group-II 
included 24(60%) male (age range 30-60 years) and 16(40%) females 
(age range 33-60years).So total male were 50(62.50%) and females 
were 30(37.50%) out of 80 patient. (Table-1) 
Clinical evaluation of oral cancer 
 On clinical examination, out of 80 patients, the most common 
site of involvement by oral cancer were Buccal mucosa (30%), 
Alveolus (27.5%),Tongue (18.75%), Palate (7.5%), Oropharynx (5%), 
Retromolar trigone (5%), Gingivo-buccal-sulcus (3.7%), Floor of 
mouth (2.5%). 
 In group-I, out of 40 patients with clinically suspected 
metastatic lymph node, the most common site of oral cancer was 
alveolus (15 patients). No patient had the involvement of gingivo-
buccal sulcus. In Group-II, the most common site of oral cancer was 
buccal mucosa (20 patients). No patient had involvement of floor of 
mouth. (Table-2) There was a significant difference between the two 
groups regarding site of involvement of oral cancer (P-value=0.003**) 
(Table-2) 
Gender-wise correlation of oral cancer with site of involvement 
 Out of 80 patients, 50 were males, 30 were females. In males 
the most common site of involvement was Buccal mucosa (18.75%), 
Tongue (13.75%), Alveolus (12.5%), Palate (5%), Retro-molar 
trigone (5%), Oropharynx (3.75%), Gingivo-buccal-sulcus (2.5%), 
and Floor of mouth (1.25%). 
 In females the most common site of involvement was 
Alveolus(15%), Buccal mucosa(11.25%),Tongue(5%), Palate (2.5%), 
Oropharynx (1.25%), Gingivobuccal-sulcus (1.25%), and Floor of 
mouth (1.25%).There was no significant difference between males 
and females regarding site involvement (P-value=0.500). (Table-3) 
Correlation of TNM staging of Oral cancer within groups 
 Out of 80 cancer patient T4 stage was noted in 47(58.75%) 
patient, T3 in 7(8.75%) patient, T2 in 21(26.25%) patient and T1 in 
5(6.25%) patient. 
 In Group-I, 33 (41.25%) patient had T4 stage, 5(6.25%) 
patients with T2 stage, 2(2.5%) patients with T3 stage. No patient 
was having T1 stage. In Group- II, T2 stage was noted in 16(20%) 
patients T4 stage was found in 14(17.5%) patients, T3 in 5(6.25%) 
patients, T1 in 5(6.25%) patients. On statistical analysis, there was a 
significant difference between groups regarding TNM staging (P-
value <0.001**) (Table-4) 
Correlation of TNM staging with site of involvement of oral 
cancer 
 T4 stage  was found most commonly involving alveolus in 
20(25%) patient, tongue in 14(17.5%) patients , buccal mucosa in 
7(8.75%) patients, palate and floor of mouth in 2(2.5%) patients each 
and oropharynx and retro molar trigone  in 1(1.25%) patient each. 
 T2 stage was found in buccal mucosa in 12(15%) patients, 
palate & retro molar trigone in 3 (3.75%) patients each, tongue, 
oropharynx and gingivo-buccal sulcus in 1(1.25%) patient in each. 
 T3 stage was found most commonly at buccal mucosa in 3 
(3.75%) patients, oropharynx 2(2.5%), alveolus and palate in 
1(1.25%) patient each. 
 T1 involved buccal mucosa and gingivo-buccal sulcus in 
2(2.5%) patients, alveolus in 1(1.2%) patient. There was a significant 
relation between site of involvement and TNM staging (P-
value<0.001**) (Table-5) 
 Although male had more T4 stage involvement but gender wise 
there was no significant difference between T staging in males and 
female (P-value=0.514)(Table-6) 
Clinical evaluation of cervical lymph nodes in patient with oral 
cancer  
 Clinical examination detected total 112 palpable lymph nodes 
80 patients with oral cancer. No. of nodes ranged from 1 to 3 in 
Group-I and from 1 to 2 in Group-II. Size of nodes ranged from 
8x6mm in Group-II to 6x5cm in Group-I. Most commonly palpated 
nodes were Level I, followed by Level II and Level III. In Level I, 
the most common nodes involved were submandibular nodes. No 
node was palpated at Level IV or Level V. 13(16.2%) patient had 
bilateral lymph node involvement ( 9 in Group-I & 4  in Group-
II).Most common site of oral cancer with bilateral lymph node 
involvement was tongue 5(38.5%) patients, alveolus 4 (30.8%) 
patients, buccal mucosa 3(23%) patients and palate 1(7.7%) patient. 
 On clinical evaluation out of those 112 nodes, 67(59.9%) were 
suspected to be metastatic in 40 patient of Group-I and 45(40.1%) 
were suspected to be reactive in 40 patient of Group-II based on 
clinical criteria to differentiate metastatic lymph nodes from reactive 
nodes. No. of nodes involved in males and females in Group-I & 
Group-II was not significant (P-value=0.398) (Table-7)  
Comparison of the results between Clinical and FNAC findings 
 Total 112 lymph nodes were evaluated clinically in both 
groups. Group-I included 67(59.9%) clinically suspected metastatic 
nodes in 40 patients with oral cancer. Group-II included 45(40.1%) 
clinically suspected reactive nodes in 40 patients with oral cancer. 
 A comparison of clinical findings with cytological findings in 
112 clinically palpable cervical lymph nodes showed that out of 67 
clinically suspected metastatic lymph nodes, 67 were confirmed for 
metastatic deposits (no false positive) and out of 45 clinically 
suspected reactive nodes 28(25%) lymph nodes proved reactive and 
17(15.1%) proved metastatic by cytology (false negative).So total 84 
(75%) nodes were diagnosed as metastatic and 28(25%) as reactive 
by FNAC. (Table-8).There was statistically significant difference 
between clinical diagnosis and FNAC findings (P-value=0.010**), 
accordingly a sensitivity of 79.8%, specificity of 100% with accuracy 
of 84.82% in patients with oral cancer. 
 
Colour Doppler Ultrasonographic evaluation of cervical lymph 
nodes in patient with oral cancer 
 During CDUS examination of these 112 cervical lymph nodes 
in the same patients, an additional 19 (17 in Group-I and 2 in Group-
II) lymph nodes were discovered which were also included in the 
overall CDUS study. So total lymph nodes evaluated by CDUS were 
131(84(64%) in Group-I and 47(36%) in Group-II) .There was a 
significant difference between Group–I and Group-II regarding 
involvement of extra nodes. (P-value=0.013*) (Table-9)     
 Most commonly evaluated nodes were Level I, 112 (85.4%) 
nodes followed by Level II 14(10.7) and Level III, 5(3.9%) nodes. At 
Level, the most common node involved were submandibular in both 
groups (Total node=109, 65 in Group-I and 44 in Group-II). No node 
was evaluated at Level IV or Level V. On comparison between 
groups similar patterns of lymph node involvement were seen but in 
Group-II, there was no node involvement at Level III. There was no 
significant difference between two group regarding pattern of nodal 
involvement (P-value=0.086) (Table-10) 
 On the basis of colour flow pattern  visible on colour Doppler 
ultrasound out of 131 lymph nodes 96(73.3%) [78 (59.4%)in Group-I 
and 18(13.9%) in Group-II] showed features of metastasis with 
81(61.8%) nodes with peripheral flow [64(48.8%) in Group-I & 17 
(13%) in Group-II], 12(9.2%) with mixed flow [11 (8.3%) in Group-I  
& 1(0.9%) in Group-II], 3(2.3%) with no flow (all in Group-I)  and 
35 (26.7%) showed features of reactive nodes with central vascular 
flow[6(4.6%) in Group-I  & 29(22.1% )in Group-II].(Table-11). 
There was a significant difference between Group–I and Group-II 
regarding flow pattern. (P-value <0.001**)(Table-11)  
 On the basis of intranodal vascular resistance indices, In 
this study the Pulsatility indices from the vessels of metastatic lymph 
nodes ranged from 1.07 to 3.85, with a mean value of 2.33+ 
0.78(mean+SD).The Pulsatility indices from the vessels of reactive 
lymph nodes ranged from 0.43 to 2.76,with a mean value of 
0.92+0.32(mean+ SD).  
 The resistivity indices from the vessels of metastatic lymph 
nodes ranged from 0.44 to 0.94, with a mean value of 0.83+ 
0.12(mean+SD). The resistivity indices from the vessels of reactive 
lymph nodes ranged from 0.32 to 0.94, with a mean value of 
0.52+0.12(mean+ SD). There was statistically significant differences 
between the mean values of PI and RI for metastatic and reactive (p-
value <0.001** for PI and RI) (Table-12).  
 On the basis of Pulsatility index (PI) & Resistivity index (RI)) 
provided by colour Doppler ultrasound out of 131 lymph nodes 
83(63.4%) [73(55.7%) in Group-I and 10 (7.7%) in Group-II] showed 
features of metastasis (PI>1.5 & RI > 0.7) and 48 (36.6%) [11 (8.3%) 
in Group-I and 37 (28.3%) in Group-II] showed features of reactive 
nodes (PI <1.5 & RI <0.7). This study showed statistically significant 
differences between two groups regarding PI and RI values. (P-value 
<0.001**) (Table-13) 
Fine needle aspiration cytology (FNAC) findings of cervical 
lymph nodes in patient with oral cancer 
 On Fine needle aspiration cytological confirmation of those 131 
lymph nodes, the result was 102 (84 in Group-I & 18 in Group-II) 
were metastatic and 29(all in Group-II) were reactive. 
Comparison of the results between clinical, CDUS and FNAC to 
find out the efficacy of CDUS 
 In the comparison of CDUS diagnosis with cytological 
diagnosis among 112 clinically evaluated cervical lymph nodes, it  
became evident that out of the 112 lymph nodes, 78(69.6%) [61 in 
Group-I & 17 in Group-II) were metastatic and 34(30.4%) [6 in 
Group-I & 28 in Group-II] were reactive by CDUS by colour flow 
pattern and 67(59.9%) [58 in Group-I & 9 in Group-II] were 
metastatic and 45(40.1%) [9 in Group-I & 36 in Group-II] were 
reactive based on colour Doppler vascular indices as compared with 
clinical diagnoses of 67(59.9%) metastatic and 45(40.1%) reactive. 
FNAC diagnosed 84 (75%) nodes as metastatic and 28(25%) as 
reactive lymph nodes. (Table-14) 
 On comparison, there was no statistical difference between 
CDUS flow pattern and FNAC (P-value=0.293).but statistically 
significant difference was found between CDUS vascular indices 
findings and FNAC (P-value=0.007**) (Table-14) 
 CDUS study of those 131 lymph nodes (which include 112 
clinically palpable lymph nodes and additional 19 lymph nodes 
discovered during CDUS), 96(73.3%) [78 in Group-I & 18 in Group-
II)] had features of metastatic lymph nodes and the remaining 
35(26.7%) lymph nodes ( 6 in Group-I & 29 in Group-II) had features 
of reactive lymph nodes. On the basis of vascular indices on CDUS 
of 131 nodes 83(63.4%) [(73 in Group-I & 10 in Group-II)] showed 
features of metastatic nodes and 48(36.6%) [(11 in Group-I & 37 in 
Group-II)] showed features of reactive nodes.  
 On Fine Needle Aspiration Cytological (FNAC) confirmation of 
those 131 lymph nodes, the result was 102(77.9%) [(84 in Group-I & 
18 in Group-II)] were metastatic and 29 (22.1%) were reactive. On 
comparison, there was no statistical difference between CDUS flow 
pattern and FNAC (P-value=0.388), but statistically significant 
difference was found between CDUS vascular indices findings and 
FNAC (P-value=0.010**) (Table-15) 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
  
 This study was conducted in the Department of Oral Medicine 
and Radiology, Tamil Nadu Government dental college and hospital, 
Chennai-3; Barnard Institute of Radiology, Madras Medical College, 
Chennai-3; Goschen Institute of Pathology, Madras Medical College, 
Chennai-3.Study comprised 80 Adult Subjects with clinically and 
histopathologically diagnosed Oral cancer of either gender with age 
range of 20-60 years. To avoid over-diagnosis of lymph nodes in 
patients with oral cancer, study was divided in two groups based on 
clinical criteria. Group-I included 40 patients with clinically 
suspected Metastatic cervical lymph nodes, Group-II included 40 
patients with clinically suspected Reactive Cervical lymph nodes. 
 All enlarged cervical lymph nodes in patients with oral cancer 
are traditionally assumed to be metastatic.20 ,63 ,50  Recent studies have 
shown that there is a tendency to over-diagnose nodes as metastatic 
in patients with oral cancer and have suggested that all clinically 
palpable cervical lymph nodes in oral cancer patients cannot be 
assumed to be metastatic but there should be a re-evaluation of the 
clinical criteria for suspicion of cervical lymph nodes in patients 
with oral cancer.28 ,29 So based on these studies, we divided study 
population into two groups, based on clinical criteria for 
differentiating metastatic nodes from reactive nodes.33 ,58  A total of 
112 lymph nodes were evaluated in 80 patients with oral cancer, 67 
nodes as clinically suspected metastatic in Group-I and 45 as 
clinically suspected reactive in Group-II.  
 CDUS correctly identified 112 cervical lymph nodes in 80 
patients with oral cancer. During CDUS evaluation, an additional 
19(17 in Group-I & 2 in Group-II) lymph nodes were discovered, 
which were either located in a clinically in-accessible region, deep 
seated, or in obese patients were obscured by the neck tissue.19 This 
resulted in a false negative rate of 14.5% (19 lymph nodes) by 
clinical examination as those nodes were totally missed during 
clinical evaluation.  
 These findings supported the study by Bruneton et al19 These 
19 additional lymph nodes were found in 14 patients (12 in Group-I 
& 2 in Group-II).By FNAC confirmation, 18 out of 19 cervical lymph 
nodes had metastatic deposits so rate of occult metastasis were 94.7% 
which is different as compared to reported by Ahmed et al2 and 
Suwarna et al as they found it to be 33%.29 This study showed that in 
patients with oral cancer, highest risk for early metastasis to lymph 
nodes were to Level I (85.4%), followed by Level II (10.7%), Level 
III (3.9%). In level I, the most commonly nodes involved by oral 
cancer were submandibular nodes (109 out of 112 level I nodes). 
These findings were comparable to the findings of Ying and Ahuja78 
and Suwarna29 et al as the reported Level II and Level III nodes as 
most commonly involved. No nodes were palpated at Level IV or 
Level V. This findings was similar to the findings of Ying78 and 
Ahuja and Suwarna et al.29  
 Most patients in this study with confirmed metastatic nodes on 
FNAC had T4 (47(58.75%) patients) stage of oral cancer at clinical 
presentation. And in T4 stage was the most common clinical 
presentation in patients with oral cancer involving the alveolus (out 
of 22 patient with alveolus involvement ,20 (90.9%) patients had T4 
stage due to bone involvement as demonstrated by radiographs) 
followed by cancer of tongue(out of 15 patient with tongue 
involvement, 14(93.3%) patients had T4 stage).  
 So from these findings, this study supported the fact that the 
risk of metastasis to cervical lymph nodes increases with increasing 
T stage of oral cancer. Also endophytic tumours as well as tumours 
involving bone are more prone for metastasis than exophytic 
tumours. These findings were similar to the findings of Carew JF et 
al20 and Suwarna et al.29  
 
Colour Doppler flow Pattern  
 The role of Doppler ultrasound in the evaluation of metastatic 
nodes is based on the fact that tumours larger than a few millimeters 
in diameter stimulate the growth of new vessels. This tumour neo-
vascularity has certain characteristics that enable a presumptive 
diagnosis of malignancy to be made. In evaluating nodal vascularity, 
Doppler ultrasound assesses two main features53,  30 ,  5 ,  8   
1. Distribution of vessels within the node, and 
2. Vascular parameters detecting intravascular resistance (RI, PI).  
 In this study, out of total 131 lymph nodes evaluated by CDUS, 
81(61.8%) [64 (48.8%) in Group-I and 17(13%) in Group-II] showed 
peripheral color flow signal, all suggestive of metastatic nodes.  
 Out of these 81 nodes all were confirmed as metastatic nodes 
by FNAC. (False positive=zero).Our study again supported the fact 
that peripheral flow is suggestive of metastatic nodes which is 
similar to previous studies.5 ,  16 ,  27. 
 In our study peripheral flow was not shown by FNAC proven 
reactive nodes. This finding was in contrast to previous studies28 ,29. 
This can be explained by difference in methodology as all patients 
were having oral cancer and patients were divided into two groups 
based on clinical criteria. 
 In metastatic lymph node involvement, destruction of hilar 
vascularity by tumour cells may result in the induction of vascular 
supply from the peripheral pre-existing vessels or from vessels in the 
peri-nodal soft tissue. Thus, they have peripheral flow. 
 Out of 131 nodes 35(26.7%) [6(4.6%) in Group-I and 
29(22.1%) in Group-II] nodes showed central vascular flow, 33 nodes 
proved to be reactive and 2 metastatic, by FNAC. 
 Reactive nodes tend to have prominent hilar/central vascularity 
due to the increase in vessel diameter and blood flow as seen in 33 
reactive nodes.8   This finding was consistent with other studies, 
suggesting that presence of central flow is indicator of reactive 
nodes.53,63 ,68 ,29 ,5 ,24   Presence of central flow in two metastatic lymph 
nodes was contradictory finding. This finding was comparable to the 
study by Sato et al63  and Steinkamp et al68. 
 The reason for this could be the presence of micro-metastases 
at the early stage of lymph node involvement, which could not be 
detected by CDUS as intranodal vascular alterations take place at a 
relatively late stage of metastasis.68 ,71 
 Another reason for central flow in metastatic nodes could be 
increased local immune reaction in the early stage of micro-
infiltration, leading to increased vascularity. The original 
architecture of the lymph node is rarely altered, leading to central 
vascular flow pattern in metastatic node.74,78  
 12(9.2%) [11(8.3%) in Group-I and 1(0.9%) in Group-II] lymph 
nodes showed mixed vascularity, which were confirmed as metastatic 
nodes by FNAC. This finding was consistent with the findings of 
Chih-Hsiu Wu et al78 and SB Dangore et al28. 
 Mixed vascular flow of the metastatic node can be explained by 
two pathogeneses. First, as the tumour nests replace the node, the 
pre-existing nodal vessels may be proliferated and transformed into 
feeding vessels by tumour angiogenesis, resulting in central aberrant 
nodal vessels. Second, advanced tumoural infiltration of a node will 
destroy the hilar blood supply, resulting in induction of the vascular 
supply from the peripheral pre-existing vessel or vessels in peri-
nodal connective tissue, which may be accelerated by extra-capsular 
invasion.53This study showed no flow in 3(2.3%) FNAC proved 
metastatic cervical lymph nodes. This finding was consistent with the 
previous studies.53 ,16 ,28 
 There are studies that showed that absence of flow in a lymph 
node is an important CDUS feature suggesting its metastatic nature. 
Reason for no flow in metastatic nodes could be the total replacement 
of the whole node by necrosed and keratinized tumour tissue leading 
to absence of vascular patterns.63 ,68 
 In our study no FNAC proven reactive nodes showed 
peripheral, mixed or no flow. This finding was in contrast to 
previous studies.28 ,  29 This can be explained by difference in 
methodology as all patients were having oral cancer and patients 
were divided into two groups based on clinical criteria, which were 
not the case in previous studies. 
 On the basis of the presence of colour flow pattern, the 
sensitivity and specificity to differentiate between metastatic and 
reactive lymph node involvement in oral cancer patients were 94.1% 
and 100% respectively with a accuracy of 95.4%.As compared with a 
previous study, our study showed comparable sensitivity but high 
specificity and high accuracy.28,29  
 Overall results of colour Doppler flow criteria were highly 
statistically significant in this study (P<0.001). 
Vascular parameters  (PI & RI) 
 In the present study, higher values for both PI & RI were found 
in patients with metastatic lymph nodes, and lower values than the 
cut-off values for reactive nodes. These findings were consistent with 
most of the previous studies.25 ,28 ,29 ,53 ,79 
 Reason for higher values for metastatic nodes can be explained 
by the fact that as tumour cells spread into the lymph node, they 
grow and replace a large portion of the lymph node. Finally, the 
lymph node is totally replaced by tumour cells. At this stage, tumour 
cells compress vessels in the lymph node because of the limited 
space therein. This vascular compression by tumour cells increases 
vascular resistance.8,25 The lower values found in reactive node are 
because of dilatation of blood vessels in reactive nodes. 
 The role of intravascular resistance parameters (RI, PI) in 
differentiating metastatic from reactive nodes has been a subject of 
controversy. Some studies have suggested that the vessels in a 
metastatic node had lower resistance (as reflected by a low RI) due to 
the absence of a muscle layer in tumour vessels and the presence of 
arterio-venous shunting.5,22 ,68  
 According to Ahuja et al5 the reason for the contrasting results 
of the values of RI and PI in some studies is the differences in 
methodology and vessel sampling used for evaluating the RI and PI, 
such as (1) which node should be evaluated, and (2) how the RI and 
PI are calculated. In our study, the mean of randomly obtained RI 
and PI within the node was used. 
 Different cut-off points for RI and PI were used in previous 
studies25 ,13 ,53 ,18 ,65 In our study, we applied the cut-off points 
suggested by Wu et al73 (RI= 0.7 and PI=1.5) and found that the 
sensitivity and specificity in our population were 81.4% and 100% 
respectively with an accuracy of 85.5%, by applying those cut-off 
points. This also shows that flow pattern is more sensitive parameter 
when compared to vascular indices in differentiating metastatic 
nodes from reactive nodes. This finding is consistent with previous 
studies.28 ,29  
 The results of our study for these criteria showed that there was 
a statistically significant difference between the mean values of RI 
and PI for metastatic and reactive lymph nodes (P<0.001 for RI and 
P<0.001 for PI), which were comparable with previous studies by 
Steinkamp et al68  and Shirakawa et al65  while the findings of the 
other studies showed that differentiation between metastatic and 
lymph node enlargement is not possible solely on the basis of these 
Doppler indices.53 ,9 ,22  
Comparison of Clinical and CDUS findings with FNAC as standard 
 As in our study, we used the clinical criteria to differentiate 
metastatic lymph nodes from reactive nodes in patients with oral 
cancer instead of using traditional assumption that each and every 
enlarged lymph node is metastatic in patients with oral cancer, the 
false positive rate was zero i.e. there was no node which was 
clinically suspected as metastatic but shown reactive as by FNAC as 
a standard. So the specificity of clinical criteria 100%, with a 
sensitivity of 79.8% and accuracy of 84.8%. 
 Out of 112 clinically palpated nodes, CDUS showed 78 nodes 
as metastatic and 34 nodes as reactive by colour flow pattern and 67 
as metastatic & 45 as reactive by vascular indices as compared to 84 
metastatic nodes and 28 reactive nodes given by standard FNAC. 
False positive rate for metastatic nodes by CDUS flow pattern and by 
vascular indices were zero i.e. no reactive nodes were shown as 
metastatic by both. So the sensitivity of CDUS by vascular flow 
pattern was 92.85%, specificity of 100%, with accuracy of 94.6% and 
by vascular indices the sensitivity was 79.8%, specificity of 100%, 
and accuracy of 84.8%. 
 CDUS showed 96 nodes as metastatic and 35 nodes as reactive 
by colour flow pattern and 83 as metastatic & 48 as reactive by 
vascular indices as compared to 102 metastatic nodes and 29 reactive 
nodes given by standard FNAC. False positive rate for metastatic 
nodes by CDUS flow pattern and by vascular indices were zero i.e. 
no reactive nodes were shown as metastatic by both. So the 
sensitivity of CDUS by vascular flow pattern was 94.1%, specificity 
of 100%, with accuracy of 95.4% and by vascular indices the 
sensitivity was 81.4%, specificity of 100%, and accuracy of 85.5%. 
 On comparison the CDUS flow pattern was more accurate in 
differentiating metastatic from reactive nodes in patients with oral 
cancer. Additionally 19 nodes were discovered by CDUS as compared 
to clinical palpation .This means that CDUS is more reliable than 
clinical examination and there is improvement in detection of node 
metastasis in oral cancer by CDUS as reported by previous 
studies.53 ,80  
 According to this study the overall rate of metastatic cervical 
nodes in oral cancer was 77.9% (102 out of 131 nodes were 
metastatic). This finding was comparable to study of Dietmar 
Koischwitz et al43  they reported lymph node metastatic rate of 80% in 
patients with squamous cell carcinoma. However, Spiro JD, et al67  
and Dangore et al29  reported a lower rate of lymph node metastasis 
(18.57%). 
 
 
 
 
SUMMARY AND CONCLUSION 
 
 This study was conducted in the Department of Oral Medicine 
and Radiology, Tamil Nadu Government dental college and hospital, 
Chennai-3; Barnard Institute of Radiology, Madras Medical College, 
Chennai-3; Goschen Institute of Pathology, Madras Medical College, 
Chennai-3.Study comprised 80 Adult Subjects with clinically and 
histopathologically diagnosed Oral cancer of either gender with age 
range of 20-60 years. To avoid over-diagnosis of lymph nodes in 
patients with oral cancer, study was divided in two groups based on 
clinical criteria. Group-I included 40 patients with clinically 
suspected Metastatic cervical lymph nodes, Group-II included 40 
patients with clinically suspected Reactive Cervical lymph nodes. 
 In summary our study support the fact that each node involved 
in patient with oral cancer should not be considered as metastatic, 
which can lead to unnecessarily treatment of neck. 
 Our study also showed that risk of metastasis is more in oral 
cancer patient with advance staging (T4 in 58.75% patients) as well 
as in patient with bone involvement. 
 In this study we found that most commonly involved cervical 
lymph nodes in patients with oral cancer are Level (85.4%) followed 
by Level II (10.7%) and Level III (3.9%). Bilateral lymph node was 
more common with oral cancer involving tongue followed by 
alveolus. 
 Cervical lymph node involvement is a single most important 
factor in treatment and prognosis in patient with oral cancer, as 
regional metastasis decreases the survival rate significantly. So there 
is need to evaluate the neck thoroughly for any lymph node 
involvement in oral cancer patients which is not possible clinically 
(sensitivity=79.8%, specificity=100%, accuracy=84.8%) as our study 
have shown. 
 CDUS being a non-invasive, real-time procedure and easily 
applicable tool for the detection of alterations in the vasculature of 
lymph nodes may reduce the patient morbidity and therefore is of 
great clinical importance. In our study all of the findings suggested 
superiority of CDUS over clinical evaluation. In CDUS evaluation, 
flow pattern (sensitivity=94.1%, specificity=100%, accuracy=95.4%) 
is more accurate than the vascular indices (sensitivity=81.4%, 
specificity=100%, accuracy=85.5%) in differentiating metastatic 
from reactive lymph nodes in oral cancer patients. 
 From our study we conclude that CDUS plays a definitive role 
as an adjunct to clinical evaluation of differentiating metastatic from 
reactive cervical lymph involvement in patients with oral cancer as it 
aid in grading and staging of oral cancer and can determine the 
treatment plan prognosis and morbidity by diminishing the 
possibility nodal dissection. 
 However, results of our study on diagnostic accuracy of Colour 
Doppler ultrasonography in evaluation of cervical lymph nodes in 
oral cancer patients can be validated with more studies involving 
large number of oral cancer patients.  
 
 
 
 
 
 
 
 
 
 
 
 
 
BIBLIOGRAPHY 
 
1. Adibellia ZH, Unala G, Gulb E, et al. Differentiation of benign 
and malignant cervical lymph nodes: Value of B-mode and Colour 
Doppler sonography. European Journal of Radiology 
1998;28:230-234. 
2. Ahmed MU, Khawar A, Ahmed J, et al .Occult metastasis in 
carcinoma of oral cavity. J Coll Physicians Surg 
Pak.2007;17:313:315. 
3. Ahuja A, Ying M. An overview of neck node sonography. Invest 
Radiol 2002;37:333-342. 
4. Ahuja A, Ying M. Sonography of neck lymph nodes. Part II: 
Abnormal lymph nodes. Clinical Radiology  2003;37:58;359-366. 
5. Ahuja A, Ying M, Ho SSY, et al. Distribution of intranodal 
vessels in differentiating benign from metastatic neck nodes. 
Clinical Radiology.2001;56:197-201. 
6. Ahuja A, Ying M, Yuen YJ, et al. Power Doppler sonography to 
differentiate tuberculous cervical lymphadenopathy from 
nasopharyngeal carcinoma. American Journal of 
Neuroradiology.2001;22:735-740. 
7. Ahuja A, Ying M et al. Power Doppler Sonography of cervical 
lymphadenopathy. Clinical Radiology. 2001;56:965-969. 
8. Ahuja A, Ying M et al. Power Doppler Sonography of metastatic 
nodes from papillary carcinoma of thyroid. Cervical 
lymphadenopathy. Clinical Radiology. 2001;56:284-288. 
9. Ahuja A, Ying M, King W, et al. A practical approach to 
ultrasound of cervical lymph nodes. J Laryngol 
Otol.1997;111:245-256. 
10. Ahuja A, Ying M. Evaluation of cervical lymph node vascularity: 
A comparison of colour Doppler, power Doppler and 3D power 
Doppler sonography. Ultrasound Med Biol.2004;30:1557-1564. 
11. Ahuja A, Ying M,King A. Lymph node hilus: Gray scale and 
Power Doppler sonography of cervical nodes. J Ultrasound 
Med.2001;20:987-992. 
12. Ahuja A, Ying M, Antonio G et al. Ultrasound of malignant 
cervical lymph nodes. Cancer Imaging.2008;8:48-56 
13. Ahuja AT, HO-SSY, Leung SF, et al. Metastatic adenopathy from 
Nasopharyngeal Carcinoma: Successful Response to Radiation 
Therapy Assessed by Color Duplex Sonography. American 
Journal of Radiology.1999, January; 20:151-156. 
14. Altedorneburga GS, Demhartera J, Linneb R et al. Does 
ultrasound contrast contrast agent improve the diagnostic value of 
colour and power Doppler sonography in superficial lymph node 
enlargement? European J Radiol 2003;48:252-257. 
15. American Joint Committee on Cancer Staging. American Joint 
Committee on Cancer Staging Manual. 5th edition. Philadelphia: 
Lippincott-Raven: 1997. 
16. Ariji Y, Kimura Y, Hayashi N, et al. Power Doppler sonography 
of cervical lymph nodes in patients with head and neck cancer. 
American Journal of Neuroradiology. 1998,February;19:303-307. 
17. Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. 
Am Fam Physician 2002;66:2103-2110. 
18. Brnic Z, Hebrang A. Usefulness of Doppler waveform analysis in 
differential diagnosis of cervical lymphadenopathy. Journal of 
European Radiology.2003;13:175-180. 
19. Bruneton JN, Roux P, Caramella E et al. Ear, nose and throat 
cancer, ultrasound diagnosis of metastasis to cervical lymph 
nodes. Radiology 1984;162:771-773. 
20. Carew JF, Bhuvanesh Singh B, Jatin P Shah. Cervical lymph 
nodes. In Oral cancer.UK; Martin Dunitz;2003.p.215-220. 
21. Castenholz A. Architecture of the lymph node with regard to its 
function. In: Grundmann E & Vollmer E, eds. Reaction patterns 
of the lymph node. Part 1. Cell types and functions, New York: 
Springer-Verlag, 1990:1-32. 
22. Chang DB, Yuan A, Yu CJ, et al. Differentiation of benign and 
malignant cervical lymph nodes with colour Doppler sonography. 
American Journal of Roentgenology.1994; 162:965-968. 
23. Chen CN, Cheng YM, Liang JT, et al. Colour Doppler vascularity 
index can predict distant metastasis colon cancer patients. Cancer 
Research.2000 June;60:2892-2897. 
24. Chikui T, Yonetsu K, Nakamura T. Multivariate feature analysis 
of sonographic findigs of metastatic cervical lymph nodes:  
Contribution of blood floe features revealed by power Doppler 
sonography for predicting metastasis. Am J Neuroradiol  
2000;21:561-567. 
25. Choi MY, Lee JW, Jang KJ. Distinction between benign and 
malignant cervical, axillary and inguinal lymphadenopathy: Value 
of Doppler spectral waveform analysis. American Journal of 
Roentgenology.1995;165:981-984. 
26. Cohen MB, Miller TR, and Bottles K. Classics in cytology: Note 
on fine needle aspiration of the lymphatic glands in sleeping 
sickness. Acta Cytol 1986;30(4):451-2. 
27. Connor SEJ, JFC Olli JFC Review. Imaging of malignant cervical 
lymphadenopathy. Dentomaxillofacial Radiology. 2000; 29:133-
143. 
28. Dangore SB, Degwekar SS, Bhowte RR. Evaluation of the 
efficacy of colour Doppler ultrasound in diagnosis of cervical 
lymphadenopathy. Dentomaxillofacial Radiology 2008;37:205-
212. 
29. Dangore KS, Degwekar SS, Bhowte RR et al. Utility of colour 
Doppler ultrasound in evaluating the status of cervical lymph 
nodes in oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol 
Endod 2009;108:255-263.  
30. Dragoni F, Cartoni C, Pescarmona E, et al. The role of high 
resolution pulsed and colour Doppler ultrasound in the diagnosis 
of benign and malignant lymphadenopathy. Results of 
multivariate analysis.Cancer.1999;11:1485-1491. 
31. Eida S, Sumi M, Yonetsu Y, et al. Combination of Helical CT and 
Doppler Sonography in the Follow-up of Patients with Clinical 
N0 Stage Neck Disease and Oral Cancer. American Journal of 
Radiology.2003 March;24:312-318. 
32. Evans DH, McDicken WN, Skidmore R, Woodcock JP. Doppler 
Ultrasound: Physics, Instrumentation, and Clinical Applications. 
Chichester: Wiley, 1989. 
33. Ferrer P. Lymphadenopathy: differential diagnosis and 
evaluation. Am Fam Physician 1998;58:15. 
34. Giovagnorio F, Galluzzo M, Andreoli C, et al. Colour Doppler 
sonography in the evaluation of superficial lymphomatous lymph 
nodes. J Ultrasound Med. 2002;21:403–408. 
35. Guthrie CG. Glands puncture as a diagnostic measure. Johns 
Hopkins Bull 1921;32:266-9. 
36. Hajek PC, Salomonowitz E, Turk R et al. Lymph nodes of the 
neck evaluation with ultrasound .Radiology. 1986;158:739-742. 
37. Hall FG. The functional anatomy of lymph nodes. In: Stansfeld 
AG & d’Ardenne AJ, eds. Lymph node biopsy interpretation, 
London: Churchill Livingstone, 1992:3-28. 
38. Hao SP, Ng SH. Magnetic resonance imaging versus clinical 
palpation in evaluating cervical metastasis from head and neck 
carcinoma. Otolaryngol Head Neck Surg. 2000; 123:324-327. 
39. HO SSY, Ahuja AT, Kew J, et al. Differentiation of 
lymphadenopathy in different forms of carcinoma with Doppler 
sonography 2000;55:627-631. 
40. Huang Y,Bing S, Rong W, et al. Detection of small inflammatory 
and metastatic lymph nodes in rabbits by sonography: evaluation 
with the resistive ratio. J Ultrasound Med.2008;27:233-241. 
41. K. Alam, A. Khan, F. Siddiqui, A. Jain, N. Haider & V. 
Maheshwari : Fine needle aspiration cytology (FNAC), a handy 
tool for metastatic lymphadenopathy. The Internet Journal of 
Pathology. 2010 ;10: 2. 
42. Kim BM, Kim EK, Kim MJ, Yang WI, Park CS. Sonographically 
guided core needle biopsy of cervical lymphadenopathy in 
patients without known malignancy. J Ultrasound Med 2007; 26: 
585-591. 
43. Koischwitz D, Gritzmann N. Ultrasound of the neck. Radio Clin 
North Am.2000;5:1029-1045. 
44. Koo V, Lioe TF, Spence RAJ. Fine needle aspiration cytology 
(FNAC) in the diagnosis of granulomatous lymphadenitis. Ulster 
Med J.2006; 75(1):59-64.  
45. Lee R, Valaitis J, Kalis O, Sophian A, Schultz E. Lymph node 
examination by fine needle aspiration in patients with known or 
suspected malignancy.  Acta Cytol 1987; 31: 563-572. 
46. Martinez-Gimeno C, Moro Rodriguez E, Navarro C, et al. 
Squamous cell carcinoma of  the oral cavity: A clinicopathologic 
scoring system for evaluating risk of cervical lymph node 
metastasis. Laryngoscope. 1995; 105:728-733. 
47. Mc Dicken WN, Itoskins PR. Colour Doppler Physics, Principles, 
Practice and Artifacts .In Clinical Doppler Ultrasound.2nd 
Edition. 
48. Moritz JD, Ludwig A, Oestmann JW. Contrast-enhanced colour 
Doppler sonography for evaluation of enlarged cervical lymph 
nodes in head and neck tumours. American Journal of 
Roentgenology.2000;174:1279-1284. 
49. Mountford RA, Atkinson P. Doppler ultrasound examination of 
pathologically enlarged lymph nodes. British Journal of 
Radiology.1979;52:464-467. 
50. Munsell DS, Is sentinel node biopsy a better predictor of survival 
than conventional imaging for patients with T1/T2 squamous cell 
carcinoma of the oral cavity and N0 neck disease? Evidence 
based medicine. Internet Journal of Head and Neck 
Surgery.2007;1:2. 
51. Nada al Alwan, Al Hashimi AS, Salman MM, Al Attar EA. Fine 
needle aspiration cytology versus histopathology in diagnosing 
lymph node lesion. Eastern Mediterranean Health Journal 1996; 
2: 320-325. 
52. Nakayama A, Ogawa A, Fukuta Y, et al. Relation between 
lymphatic vessel diameter and clinicopathologic parameters in 
squamous cell carcinomas of the oral region. Cancer 
1999;86:200-206. 
53. Na DG, Lim HK, Byun HS, et al. Differential diagnosis of 
cervical lymphadenopathy: Usefulness of colour Doppler 
sonography. American Journal of Roentgenology.1997; 168:1311-
1316. 
54. Okten OO, Tuncbilek N, Karakas HM. The value of qualitative 
and semiquantitative Ultrasonographic findings in the differential 
diagnosis of lymphomatous superficial lymph node enlargements. 
Turkish Journal of Cancer.2004;34(4):156-162. 
55. Okura M, Kagamuichi H, Tominaga G, et al. Morphological 
changes of regional lymph nodes  in squamous cell carcinoma of 
the oral cavity. J Oral Pathol Med 2005;34:214-219. 
56. Orell SR, Gregory F, Whitaker D. Fine Needle Aspiration 
Cytology 4th edition. Churchill Livingstone.2008. 
57. Papadimitriou CS, Kittas CN. Normal structure and function of 
lymph nodes. In: Pangalis GA & Polliack A, eds. Benign and 
malignant lymphadenopathies, Chur: Harwood Academic 
Publishers, 1993:113-30. 
58. Parisi E, Glick M. Cervical lymphadenopathy in dental patients: 
A review of clinical approach. Quintessence Int 2005;5:13-26. 
59. Peter Van Heerde, John Miliauskas. Lymph node. In Fine Needle 
Aspiration Cytology .1s t  edition.2005. 
60. Rakhshan M, Rakhshan A. The diagnostic accuracy of Fine needle 
aspiration cytology in neck lymphoid masses. Iranian Journal of 
Pathology.2009;4:147-150. 
61. Rourke C, Hendrickx P, Roth U, Brassel F, Creutzig A, Alexander 
K. Color and conventional image-directed ultrasonography: 
accuracy and sources of error in quantitative blood flow 
measurement. J Clin Ultrasound  1992;20:187–93. 
62. Sakaguchi T, Yamashita Y, Katahira K, et al. Differential 
diagnosis of small round cervical lymph nodes: Comparison of 
power Doppler US with contrast-enhanced CT and pathologic 
results. Radiation Medicine.2001;19(3):119-125. 
63. Sato N, Kawabe R, Fujita K et al. Differential diagnosis of 
cervical lymphadenopathy with intranodal colour Doppler flow 
signals in patients with oral squamous cell carcinoma. Oral Surg 
Oral Med Oral Pathol Oral Radiol Endod 1998;86:482-488. 
64. Schmid-Wendtner MH, Partscht K, Korting HC, et al. Improved 
Differentiation of Benign and Malignant Lymphadenopathy in 
Patients with Cutaneous Melanoma by Contrast-Enhanced Color 
Doppler Sonography. Arch Dermatol.2002;138:491-497. 
65. Shirakawa T, Miyamoto Y, Yamagishi J, et al. Colour/Power 
Doppler sonographic differential diagnosis of superficial 
lymphadenopathy, metastasis, malignant lymphoma and benign 
process. J Ultrasound Med.2001;20:525-532. 
66. Som PM. Lymph nodes of the neck. Radiology 1987;165:593-600. 
67. Spiro JD, Spiro RH, Shah P. Critical assessment of 
supraomohyiod neck dissection. Am J Surg.1988;156:286-289. 
68. Steinkamp HJ, Mueffelmann M, Bock JC et al. Differential 
diagnosis of lymph node lesions: A semiquantitative approach 
with colour Doppler ultrasound. British journal 
Radiology.1998;71:828-833. 
69. Sumi M, Ohki M, Nakamura T. Comparison of Sonography and 
CT for Differentiating Benign from Malignant Cervical Lymph 
Nodes in Patients with Squamous Cell Carcinoma of the Head and 
Neck. American Journal of Roentgenology.2001; 176:1019-1024. 
70. Takes RP. Staging of neck in patients with head and neck 
squamous cell cancer: Imaging techniques and biomarkers. Oral 
Onology.2004;40:656-667. 
71. Woogler JA. Micro-metastasis in Oral/Oropharyngeal squamous 
cell carcinoma: Incidence, histopathological features and clinical 
implications. Br J Oral maxillofacial Surg.1999;37:181:186. 
72. Wu CH, Shih JC, Chang YL, et al.2 dimensional and 3 
dimensional power Doppler sonographic classification of vascular 
patterns in cervical lymphadenopathy. J Ultrasound 
Med.1998;17:459-464. 
73. Wu CH, Chang YL, Hsu WC, et al. Usefulness of Doppler 
spectral analysis and power Doppler sonography in the 
differentiation of cervical lympadenopathies.AJR.1998; 171: 503-
509. 
74. Yang WT, Metreweli C. Colour Doppler flow in normal axillary 
lymph nodes. British Journal of Radiology.1998;71:381-383. 
75. Yang WT, Chang J, Metreweli C. Patients with Breast Cancer: 
Differences in Color Doppler Flow and Gray-Scale US Features 
of Benign and Malignant Axillary Lymph Nodes.Radiology.2000; 
215:568-573. 
76. Ying M, Ahuja A, Brook F. Sonography of normal cervical lymph 
node: Comparison between Chinese and white subjects. J 
Ultrasound Med.2002;21:59-65. 
77. Ying M, Ahuja A, Brook F et al. Ultrasound evaluation of neck 
lymph nodes. ASUM Ultrasound Bulletin 2003;6:9-17. 
78. Ying M, Ahuja A. Sonography of neck lymph nodes .Part 
I:Normal lymph nodes .Clinical Radilogy.2003;58:351-358. 
79. Ying M, Ahuja A, Yuen HY. Grey-scale and power Doppler 
Sonography of unusual cervical lymphadenopathy. Radiology 
Source 2004;30:449-454. 
80. Yonetsu K, Sumi M, Izumi M et al. Contribution of Doppler 
sonography blood flow information to the diagnosis of metastatic 
cervical nodes in patients with head and neck cancer: Assessment 
in relation to anatomic levels of the neck. American Journal of 
Neuroradiology.2001.22:163-169. 
81. Yusa H, Yoshida H, Iwasa S, et al. Ultrasonographic assessment 
for response to radio chemotherapy of metastatic cervical lymph 
nodes in head and neck cancer: Usefulness of grey-scale and 
colour Doppler sonography. J Ultrasound Med 2000;26:1081-
1087. 
